← Respiratory Pharmacology
SABANBRC High Yield5/5 Importance

Albuterol Respiratory Pharmacology Guide

The complete learning guide for class, mechanism, indications, adverse effects, kinetics, exam traps, and NBRC-style respiratory pharmacology.

Albuterol is the prototype short-acting beta-2 agonist used for rapid bronchodilation in asthma, COPD, and exercise-induced bronchospasm. Respiratory therapy students should immediately recognize albuterol as a rescue medication, not a controller. It treats acute bronchoconstriction by relaxing airway smooth muscle, but it does not correct the underlying airway inflammation that drives persistent asthma. That distinction is one of the most important clinical and board-exam lessons on the page. In practice, albuterol is encountered as a metered-dose inhaler, dry-powder inhaler, nebulized solution, and less commonly oral formulations. The most common RT-relevant uses are acute wheezing, asthma exacerbation, COPD exacerbation, pre-treatment before exercise-induced bronchospasm, and bronchodilator responsiveness testing. Frequent use is not a sign of good therapy; it is a warning sign that the patient may need reassessment, inhaler-technique review, and controller therapy optimization.

Clinical Pharmacology

Understand the medication before memorizing it

Start with mechanism, clinical pearls, onset, peak, duration, and deeper pharmacology explanations so the rest of the page has context.

Mechanism

How Albuterol works

Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Clinical Pearl

What to remember

Fast relief does not equal long-term control; frequent use suggests poor asthma or COPD control.

Kinetics

Onset, peak, and duration

1

Onset

About 5 minutes

2

Peak

30 to 60 minutes

3

Duration

4 to 6 hours

Overview

Clinical overview

Albuterol is the prototype short-acting beta-2 agonist used for rapid bronchodilation in asthma, COPD, and exercise-induced bronchospasm. Respiratory therapy students should immediately recognize albuterol as a rescue medication, not a controller. It treats acute bronchoconstriction by relaxing airway smooth muscle, but it does not correct the underlying airway inflammation that drives persistent asthma. That distinction is one of the most important clinical and board-exam lessons on the page. In practice, albuterol is encountered as a metered-dose inhaler, dry-powder inhaler, nebulized solution, and less commonly oral formulations. The most common RT-relevant uses are acute wheezing, asthma exacerbation, COPD exacerbation, pre-treatment before exercise-induced bronchospasm, and bronchodilator responsiveness testing. Frequent use is not a sign of good therapy; it is a warning sign that the patient may need reassessment, inhaler-technique review, and controller therapy optimization.

Class

Medication class explained

Albuterol belongs to the short-acting beta-2 agonist class, commonly abbreviated SABA. SABAs are fast-onset bronchodilators used for quick symptom relief. They differ from LABAs such as salmeterol and formoterol, which are longer-acting maintenance bronchodilators, and from anticholinergics such as ipratropium and tiotropium, which block muscarinic-mediated bronchoconstriction. The class distinction matters clinically. A SABA is selected when the patient needs rapid relief of bronchospasm. A LABA or LAMA is selected when the goal is maintenance bronchodilation. An inhaled corticosteroid is selected when the goal is airway inflammation control. NBRC-style questions commonly test whether the learner can separate these roles under pressure.

Mechanism

Mechanism deep dive

Albuterol stimulates beta-2 adrenergic receptors on bronchial smooth muscle. These receptors are Gs-protein coupled receptors that activate adenylyl cyclase, increase intracellular cyclic AMP, and activate protein kinase A. The downstream effect is reduced myosin light-chain phosphorylation, lower effective intracellular calcium activity, and relaxation of airway smooth muscle. This mechanism explains both the therapeutic effect and many adverse effects. Bronchial smooth-muscle relaxation produces rapid bronchodilation. Beta-2 stimulation in skeletal muscle contributes to tremor and jitteriness. High doses or systemic absorption can produce tachycardia, palpitations, and arrhythmia risk because beta receptors are also present in cardiovascular tissue. Beta-2 stimulation can shift potassium intracellularly, which explains hypokalemia during repeated or high-dose therapy.

Receptors

Receptor physiology

Beta-2 receptors are abundant in bronchial smooth muscle, but they are not exclusive to the lungs. They are also found in skeletal muscle, vascular smooth muscle, and portions of cardiac tissue. This receptor distribution explains why a medication intended for the airway can still cause tremor, tachycardia, palpitations, hypokalemia, and metabolic effects at higher doses. For learners, the key receptor pathway is: beta-2 receptor stimulation increases cAMP, which relaxes bronchial smooth muscle. The common misconception is that albuterol blocks receptors or works like ipratropium. It does not. Albuterol stimulates beta-2 receptors; ipratropium blocks muscarinic receptors.

Use

Rescue vs controller role

Albuterol is a rescue bronchodilator. It is used when the patient needs rapid relief of bronchospasm, wheezing, chest tightness, or exercise-induced symptoms. It is not a controller medication because it does not provide sustained anti-inflammatory treatment for asthma. This is a major exam and clinical safety point. A patient who needs albuterol frequently may be poorly controlled, using the device incorrectly, under-treated with controller therapy, or experiencing worsening disease. In asthma, modern guideline language discourages SABA-only management for persistent disease because airway inflammation requires inhaled corticosteroid-containing therapy. In COPD, albuterol may be used for immediate symptom relief, especially during exacerbations, but long-acting bronchodilators drive maintenance control.

Kinetics

Pharmacokinetics

Inhaled albuterol acts primarily at the airway surface with limited systemic absorption at usual doses. It has a rapid clinical onset, commonly within about 5 to 15 minutes depending on formulation and technique. Peak bronchodilator effect generally occurs later than initial symptom relief, often around 30 to 60 minutes. The practical duration is short, commonly taught as about 3 to 6 hours. Albuterol is metabolized largely to inactive sulfate conjugates and eliminated primarily in the urine. Systemic exposure increases with repeated dosing, high-dose nebulization, oral formulations, and poor technique that increases swallowed drug. High-dose or continuous therapy deserves monitoring for tachycardia, hypokalemia, hyperglycemia, and ECG changes in high-risk patients.

Administration

Dosing and administration

Common adult inhaler dosing is 1 to 2 inhalations every 4 to 6 hours as needed, depending on product labeling and clinical instruction. Exercise-induced bronchospasm prevention is commonly taught as 2 puffs about 15 to 30 minutes before exercise. Nebulized dosing commonly uses 2.5 mg per treatment in many adult and older pediatric scenarios, with repeated dosing during acute exacerbations according to protocol. Device technique is part of dosing. A correctly used MDI with spacer can be highly effective, while poor technique can make an appropriate dose fail. Patients should know whether they are using an MDI, DPI, or nebulizer because inhalation pattern differs. MDIs generally require slow coordinated inhalation, while DPIs require a stronger inspiratory effort.

Safety

Safety warnings

The major contraindication is hypersensitivity to albuterol or formulation components. Clinically important warnings include paradoxical bronchospasm, cardiovascular stimulation, excessive use, hypokalemia, hyperglycemia, and immediate hypersensitivity reactions. Use caution in patients with tachyarrhythmias, significant cardiovascular disease, hyperthyroidism, seizure disorders, or unusual sensitivity to sympathomimetics. A worsening need for albuterol is a red flag. Patients should not simply increase rescue inhaler use indefinitely. Increased frequency can indicate worsening asthma, COPD exacerbation, poor inhaler technique, inadequate controller therapy, or another diagnosis masquerading as bronchospasm.

Interactions

Drug interactions

Important interactions include nonselective beta-blockers, which can blunt bronchodilation and may worsen bronchospasm. Other sympathomimetics can increase cardiovascular adverse effects. Monoamine oxidase inhibitors and tricyclic antidepressants may potentiate cardiovascular effects. Non-potassium-sparing diuretics can worsen hypokalemia, especially during high-dose beta-agonist therapy. Digoxin concentrations may be affected in some patients, so monitoring may be appropriate in high-risk clinical contexts.

Monitoring

Monitoring recommendations

Monitor symptom frequency, rescue-inhaler use, heart rate, blood pressure, oxygenation, breath sounds, work of breathing, and objective response when available. In spirometry, bronchodilator responsiveness is commonly assessed by comparing pre- and post-bronchodilator FEV1 after albuterol administration. During repeated nebulized treatments or continuous albuterol, monitor for tachycardia, tremor, hypokalemia, hyperglycemia, and arrhythmia risk. Respiratory therapists should also monitor technique, spacer use, dose counter status, cleaning habits, and whether the patient can coordinate the selected device.

Clinical Practice

How this medication is used at the bedside

Review common indications, expected adverse effects, contraindications, cautions, and safety issues in a clinically useful order.

Quick facts

Subclass
SABA
NBRC importance
5/5
Difficulty
1/5
Brands
Ventolin, ProAir, Proventil
5/5
NBRC importance
44
Study facts
242
Practice questions
2026
Updated

Common indications

  • Acute bronchospasm
  • Asthma exacerbation
  • COPD exacerbation
  • Exercise-induced bronchospasm prevention

Adverse effects

  • Tremor
  • Tachycardia
  • Palpitations
  • Nervousness
  • Hypokalemia
  • Paradoxical bronchospasm

Contraindications

  • Hypersensitivity to albuterol or formulation components

Cautions and safety issues

  • Use caution with tachyarrhythmias
  • Use caution with significant cardiovascular disease
  • May worsen hypokalemia at higher doses
  • Nonselective beta blockers may blunt effect

RT & NBRC Mastery

Respiratory therapy exam and bedside mastery

Move from reference knowledge into board-style reasoning, adaptive practice, common distractors, and high-yield clinical scenarios.

NBRC-style question

NBRC-style pharmacology review

A patient scenario involves acute asthma exacerbation with wheezing. Which medication concept should the respiratory therapy student recognize?

High-yield answer

Albuterol belongs to Short-Acting Beta Agonists.

Interactive practice

The Adaptive Exam Simulator

Use the complete guide on this page to learn the medication, then switch into the adaptive simulator to test yourself with scored practice, missed-concept review, and NBRC-style clinical reasoning.

ClassPractice
MechanismPractice
Clinical usePractice
Adverse effectsPractice
ScenarioPractice
Launch Adaptive Practice

Common Exam Traps

These are the answer choices, mechanisms, or medication classes most commonly confused with this medication on RT school and NBRC-style exams.

  • Long-acting beta agonist
  • Short-acting muscarinic antagonist
  • Inhaled corticosteroid
  • Blocks muscarinic receptors
  • Reduces airway inflammation as primary action

High-Yield Clinical Scenarios

  • Acute asthma exacerbation with wheezing
  • COPD exacerbation with bronchospasm
  • Pre-treatment before exercise-induced bronchospasm

Clinical decision points

  • Select albuterol for acute bronchospasm or wheezing when rapid bronchodilation is needed.
  • Use albuterol before exercise when prescribed for exercise-induced bronchospasm prevention.
  • Escalate evaluation when albuterol is needed more frequently than expected.
  • Consider ipratropium addition in COPD exacerbation or severe obstructive exacerbation protocols.
  • Monitor potassium during high-dose or continuous therapy, especially with diuretics.
  • Avoid nonselective beta-blockers when possible in patients relying on beta-agonist bronchodilation.
  • Assess inhaler technique before labeling therapy ineffective.

Expanded exam traps

  • Albuterol is a SABA, not a LABA.
  • Albuterol is a rescue medication, not a controller.
  • Albuterol stimulates beta-2 receptors; it does not block muscarinic receptors.
  • Tremor and tachycardia are expected beta-agonist effects, not necessarily allergy.
  • Frequent albuterol use suggests poor control.
  • Salmeterol should not be selected for acute rescue.
  • Ipratropium is SAMA; albuterol is SABA.
  • High-dose albuterol can lower potassium.
  • Poor inhaler technique can mimic medication failure.
  • Nebulizers are not automatically superior to MDI with spacer.

Patient teaching

  • Use albuterol exactly as prescribed and do not keep increasing doses without clinical review.
  • Know whether the device is an MDI, DPI, or nebulizer because technique differs.
  • If using an MDI, shake when required, exhale first, inhale slowly during actuation, and hold the breath after inhalation.
  • Use a spacer or valved holding chamber when recommended.
  • Track the dose counter so the inhaler is not empty during an emergency.
  • Report frequent rescue use, worsening symptoms, chest pain, severe palpitations, or poor response.

RT considerations

  • Assess breath sounds, work of breathing, oxygenation, heart rate, and response before and after treatment.
  • Verify indication: wheeze, bronchospasm, bronchodilator response testing, EIB prevention, or COPD/asthma exacerbation protocol.
  • Check for tachycardia, tremor, hypokalemia risk, and beta-blocker use.
  • Evaluate device technique and spacer use rather than assuming medication failure.
  • Recognize that frequent SABA use signals poor control and should trigger provider communication.
  • For COPD exacerbations, anticipate combined SABA/SAMA therapy such as albuterol plus ipratropium.

Device technique

  • MDI technique: sit upright, shake if required, exhale fully, seal lips, actuate at the start of a slow deep breath, inhale fully, and hold breath.
  • Use one puff at a time in a spacer; do not spray multiple puffs into the chamber at once.
  • DPI technique requires a forceful deep inhalation and should not be treated like an MDI.
  • Nebulizer technique generally uses relaxed tidal breathing with occasional deep breaths until the treatment is complete.
  • Prime new or unused inhalers according to product instructions.
  • Clean the actuator or nebulizer parts as directed to prevent clogging and contamination.

Guidelines

Guideline-based clinical context

Connect medication facts to the larger respiratory care guidelines, disease-state recommendations, and clinical decision frameworks.

Guidelines

Guideline summary

ATS

For exercise-induced bronchospasm, inhaled SABA before exercise is a key preventive strategy. Persistent or frequent need should prompt controller evaluation.

FDA

Product labeling emphasizes bronchospasm treatment or prevention, exercise-induced bronchospasm prevention, correct priming and cleaning, and warnings for paradoxical bronchospasm, cardiovascular effects, hypokalemia, hypersensitivity, and excessive use.

GINA

Asthma should not be managed as SABA-only therapy when persistent disease is present. Albuterol remains an acute reliever, but controller therapy with inhaled corticosteroid-containing treatment is central to risk reduction.

GOLD

For COPD exacerbations, short-acting bronchodilators such as albuterol, with or without ipratropium, are commonly used for immediate relief. Maintenance control relies on long-acting bronchodilators.

NBRC

Recognize albuterol as a SABA rescue bronchodilator. Do not confuse it with LABA, SAMA, LAMA, or ICS therapy.

Study Tools

Practice, recall, and retention

Use mini cases, flashcards, FAQs, and related concepts to turn the medication page into a high-retention study experience.

FAQ

Common questions

What is albuterol used for?

Albuterol is used for rapid relief of bronchospasm in asthma, COPD, and exercise-induced bronchospasm prevention.

How does albuterol work?

Albuterol stimulates beta-2 adrenergic receptors, increases cAMP, and relaxes bronchial smooth muscle.

Is albuterol a rescue inhaler?

Yes. Albuterol is a short-acting rescue bronchodilator used for acute symptoms, not long-term control.

Is albuterol a steroid?

No. Albuterol is a beta-2 agonist bronchodilator, not an inhaled corticosteroid.

Why does albuterol cause tremor?

Tremor occurs because beta-2 receptors are also present in skeletal muscle.

Can albuterol cause tachycardia?

Yes. Tachycardia and palpitations can occur, especially with high doses, systemic absorption, or cardiovascular sensitivity.

Can albuterol lower potassium?

Yes. Beta-2 stimulation can shift potassium into cells and cause hypokalemia during high-dose or repeated therapy.

What is the difference between albuterol and levalbuterol?

Levalbuterol is the R-enantiomer of albuterol. Both are SABAs used for rescue bronchodilation, and major clinical superiority is debated.

What is the difference between albuterol and ipratropium?

Albuterol stimulates beta-2 receptors, while ipratropium blocks muscarinic receptors. They are often combined in COPD exacerbations.

What should frequent albuterol use suggest?

Frequent albuterol use suggests poor control, poor technique, worsening disease, or the need to reassess controller therapy.

Knowledge graph

Related concepts

Also known as

AlbuterolAlbuterol sulfateSalbutamolVentolinVentolin HFAProAirProAir HFAProAir RespiClickProAir DigihalerProventilProventil HFAAccuNebRescue inhalerSABA

Related conditions

AsthmaCOPDExercise-induced bronchospasmBronchospasmWheezingHyperkalemia adjunct use

Related classes

SABAShort-acting beta agonistBronchodilatorSympathomimeticBeta-2 agonistLABASAMALAMAICS

Related devices

MDIMetered-dose inhalerDPIDry powder inhalerNebulizerSpacerValved holding chamber

Related guidelines

GINAGOLDATSCHESTFDAAARCNBRC

Practice Questions

Complete question bank

Work through 242 board-style and clinical reasoning questions for this medication, organized by concept area.

Complete Learning Guide

Albuterol practice questions and explanations

These board-style questions are part of the complete learning guide. Answers and explanations are visible here for broad review and SEO, while the adaptive simulator provides the true testing experience.

242
Questions
Medication Class (20)Mechanism of Action (81)Indications and Clinical Use (44)Contraindications, Safety, and Interactions (44)Adverse Effects (20)Clinical Scenarios and NBRC Reasoning (33)

Question group

Medication Class

20 questions
Question 1Difficulty 1/5

Which bronchodilator category contains Albuterol?

  1. A.SABA/SAMA combination
  2. B.Inhaled antibiotic
  3. C.LABA/LAMA/ICS triple therapy
  4. D.Short-Acting Beta Agonists

Correct answer

Short-Acting Beta Agonists

Explanation

Albuterol is classified as Short-Acting Beta Agonists. This matters because class determines onset, role, adverse effects, and rescue-versus-controller use.

Question 2Difficulty 1/5

Select the best classification for Albuterol.

  1. A.Systemic corticosteroid
  2. B.Leukotriene receptor antagonist
  3. C.Phosphodiesterase-4 inhibitor
  4. D.Short-Acting Beta Agonists

Correct answer

Short-Acting Beta Agonists

Explanation

Albuterol is classified as Short-Acting Beta Agonists. This matters because class determines onset, role, adverse effects, and rescue-versus-controller use.

Question 3Difficulty 2/5

Albuterol is best classified as which medication type?

  1. A.Systemic corticosteroid
  2. B.Mucolytic
  3. C.Pulmonary vasodilator
  4. D.Short-Acting Beta Agonists

Correct answer

Short-Acting Beta Agonists

Explanation

Albuterol is classified as Short-Acting Beta Agonists. This matters because class determines onset, role, adverse effects, and rescue-versus-controller use.

Question 4Difficulty 2/5

Albuterol is best classified as which medication type?

  1. A.Surfactant
  2. B.Long-acting beta2 agonist (LABA)
  3. C.Monoclonal antibody
  4. D.Short-Acting Beta Agonists

Correct answer

Short-Acting Beta Agonists

Explanation

Albuterol is classified as Short-Acting Beta Agonists. This matters because class determines onset, role, adverse effects, and rescue-versus-controller use.

Question 5Difficulty 2/5

Albuterol is best classified as which medication type?

  1. A.Long-acting muscarinic antagonist (LAMA)
  2. B.SABA/SAMA combination
  3. C.Mast cell stabilizer
  4. D.Short-Acting Beta Agonists

Correct answer

Short-Acting Beta Agonists

Explanation

Albuterol is classified as Short-Acting Beta Agonists. This matters because class determines onset, role, adverse effects, and rescue-versus-controller use.

Question 6Difficulty 3/5

A patient receives Albuterol in the ED. Which medication class should be documented?

  1. A.Short-acting muscarinic antagonist (SAMA)
  2. B.Mast cell stabilizer
  3. C.ICS/LABA combination
  4. D.Short-Acting Beta Agonists

Correct answer

Short-Acting Beta Agonists

Explanation

Albuterol is classified as Short-Acting Beta Agonists. This matters because class determines onset, role, adverse effects, and rescue-versus-controller use.

Question 7Difficulty 3/5

Which pharmacologic family includes Albuterol?

  1. A.Leukotriene receptor antagonist
  2. B.Methylxanthine
  3. C.LABA/LAMA/ICS triple therapy
  4. D.Short-Acting Beta Agonists

Correct answer

Short-Acting Beta Agonists

Explanation

Albuterol is classified as Short-Acting Beta Agonists. This matters because class determines onset, role, adverse effects, and rescue-versus-controller use.

Question 8Difficulty 3/5

Albuterol is best classified as which medication type?

  1. A.Inhaled corticosteroid (ICS)
  2. B.SABA/SAMA combination
  3. C.Carbonic anhydrase inhibitor
  4. D.Short-Acting Beta Agonists

Correct answer

Short-Acting Beta Agonists

Explanation

Albuterol is classified as Short-Acting Beta Agonists. This matters because class determines onset, role, adverse effects, and rescue-versus-controller use.

Question 9Difficulty 4/5

Which pharmacologic family includes Albuterol?

  1. A.Inhaled corticosteroid (ICS)
  2. B.Carbonic anhydrase inhibitor
  3. C.LABA/LAMA combination
  4. D.Short-Acting Beta Agonists

Correct answer

Short-Acting Beta Agonists

Explanation

Albuterol is classified as Short-Acting Beta Agonists. This matters because class determines onset, role, adverse effects, and rescue-versus-controller use.

Question 10Difficulty 4/5

Select the best classification for Albuterol.

  1. A.Carbonic anhydrase inhibitor
  2. B.LABA/LAMA combination
  3. C.Mast cell stabilizer
  4. D.Short-Acting Beta Agonists

Correct answer

Short-Acting Beta Agonists

Explanation

Albuterol is classified as Short-Acting Beta Agonists. This matters because class determines onset, role, adverse effects, and rescue-versus-controller use.

Question 11Difficulty 4/5

Which bronchodilator category contains Albuterol?

  1. A.ICS/LABA combination
  2. B.Systemic corticosteroid
  3. C.Monoclonal antibody
  4. D.Short-Acting Beta Agonists

Correct answer

Short-Acting Beta Agonists

Explanation

Albuterol is classified as Short-Acting Beta Agonists. This matters because class determines onset, role, adverse effects, and rescue-versus-controller use.

Question 12Difficulty 5/5

A patient receives Albuterol in the ED. Which medication class should be documented?

  1. A.SABA/SAMA combination
  2. B.Long-acting muscarinic antagonist (LAMA)
  3. C.Phosphodiesterase-4 inhibitor
  4. D.Short-Acting Beta Agonists

Correct answer

Short-Acting Beta Agonists

Explanation

Albuterol is classified as Short-Acting Beta Agonists. This matters because class determines onset, role, adverse effects, and rescue-versus-controller use.

Question 13Difficulty 5/5

An RT administers Albuterol for bronchospasm. Which drug class is being used?

  1. A.Methylxanthine
  2. B.ICS/LABA combination
  3. C.Mast cell stabilizer
  4. D.Short-Acting Beta Agonists

Correct answer

Short-Acting Beta Agonists

Explanation

Albuterol is classified as Short-Acting Beta Agonists. This matters because class determines onset, role, adverse effects, and rescue-versus-controller use.

Question 14Difficulty 5/5

Which pharmacologic family includes Albuterol?

  1. A.SABA/SAMA combination
  2. B.Mucolytic
  3. C.Carbonic anhydrase inhibitor
  4. D.Short-Acting Beta Agonists

Correct answer

Short-Acting Beta Agonists

Explanation

Albuterol is classified as Short-Acting Beta Agonists. This matters because class determines onset, role, adverse effects, and rescue-versus-controller use.

Question 15Difficulty 5/5

Select the best classification for Albuterol.

  1. A.SABA/SAMA combination
  2. B.Methylxanthine
  3. C.LABA/LAMA/ICS triple therapy
  4. D.Short-Acting Beta Agonists

Correct answer

Short-Acting Beta Agonists

Explanation

Albuterol is classified as Short-Acting Beta Agonists. This matters because class determines onset, role, adverse effects, and rescue-versus-controller use.

Question 16Difficulty 5/5

Which pharmacologic family includes Albuterol?

  1. A.Pulmonary vasodilator
  2. B.ICS/LABA combination
  3. C.Carbonic anhydrase inhibitor
  4. D.Short-Acting Beta Agonists

Correct answer

Short-Acting Beta Agonists

Explanation

Albuterol is classified as Short-Acting Beta Agonists. This matters because class determines onset, role, adverse effects, and rescue-versus-controller use.

Question 17Difficulty 5/5

Select the best classification for Albuterol.

  1. A.Pulmonary vasodilator
  2. B.Mucolytic
  3. C.SABA/SAMA combination
  4. D.Short-Acting Beta Agonists

Correct answer

Short-Acting Beta Agonists

Explanation

Albuterol is classified as Short-Acting Beta Agonists. This matters because class determines onset, role, adverse effects, and rescue-versus-controller use.

Question 18Difficulty 5/5

Select the best classification for Albuterol.

  1. A.SABA/SAMA combination
  2. B.LABA/LAMA/ICS triple therapy
  3. C.Leukotriene receptor antagonist
  4. D.Short-Acting Beta Agonists

Correct answer

Short-Acting Beta Agonists

Explanation

Albuterol is classified as Short-Acting Beta Agonists. This matters because class determines onset, role, adverse effects, and rescue-versus-controller use.

Question 19Difficulty 5/5

An RT administers Albuterol for bronchospasm. Which drug class is being used?

  1. A.Mast cell stabilizer
  2. B.LABA/LAMA combination
  3. C.Systemic corticosteroid
  4. D.Short-Acting Beta Agonists

Correct answer

Short-Acting Beta Agonists

Explanation

Albuterol is classified as Short-Acting Beta Agonists. This matters because class determines onset, role, adverse effects, and rescue-versus-controller use.

Question 20Difficulty 5/5

Albuterol represents which respiratory medication class?

  1. A.Phosphodiesterase-4 inhibitor
  2. B.LABA/LAMA combination
  3. C.Short-acting muscarinic antagonist (SAMA)
  4. D.Short-Acting Beta Agonists

Correct answer

Short-Acting Beta Agonists

Explanation

Albuterol is classified as Short-Acting Beta Agonists. This matters because class determines onset, role, adverse effects, and rescue-versus-controller use.

Question group

Mechanism of Action

81 questions
Question 1Difficulty 1/5

An RT administers Albuterol. Which mechanism explains its effect?

  1. A.Inhibits phosphodiesterase-4 increasing intracellular cAMP
  2. B.Suppresses airway inflammation through glucocorticoid receptor activation
  3. C.Stimulates surfactant production
  4. D.Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Correct answer

Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Explanation

Albuterol works by: Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Question 2Difficulty 1/5

Which pharmacologic action is most consistent with Albuterol?

  1. A.Breaks disulfide bonds within mucus
  2. B.Provides exogenous pulmonary surfactant
  3. C.Blocks cysteinyl leukotriene receptors
  4. D.Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Correct answer

Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Explanation

Albuterol works by: Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Question 3Difficulty 1/5

Which receptor action best explains how Albuterol relieves bronchospasm?

  1. A.Increases intracellular cAMP
  2. B.Relaxes bronchial smooth muscle
  3. C.Activates adenylyl cyclase through Gs signaling
  4. D.Stimulates beta-2 adrenergic receptors

Correct answer

Stimulates beta-2 adrenergic receptors

Explanation

Albuterol is a short-acting beta-2 agonist that stimulates beta-2 receptors on airway smooth muscle.

Question 4Difficulty 1/5

After beta-2 receptor stimulation by Albuterol, which intracellular messenger increases?

  1. A.Provides exogenous surfactant
  2. B.Relaxes bronchial smooth muscle
  3. C.Blocks muscarinic M3 receptors
  4. D.Increases intracellular cAMP

Correct answer

Increases intracellular cAMP

Explanation

Beta-2 receptor stimulation activates Gs signaling and adenylyl cyclase, increasing cAMP.

Question 5Difficulty 1/5

What is the intended airway smooth muscle effect of Albuterol?

  1. A.Inhibits phosphodiesterase-4
  2. B.Stimulates beta-2 adrenergic receptors
  3. C.Blocks muscarinic M3 receptors
  4. D.Relaxes bronchial smooth muscle

Correct answer

Relaxes bronchial smooth muscle

Explanation

The intended respiratory effect is bronchial smooth muscle relaxation and bronchodilation.

Question 6Difficulty 1/5

Which signaling pathway is most directly associated with beta-2 agonist activity from Albuterol?

  1. A.Blocks leukotriene receptors
  2. B.Inhibits phosphodiesterase-4
  3. C.Relaxes bronchial smooth muscle
  4. D.Activates adenylyl cyclase through Gs signaling

Correct answer

Activates adenylyl cyclase through Gs signaling

Explanation

Beta-2 receptors are Gs-coupled receptors that activate adenylyl cyclase and increase cAMP.

Question 7Difficulty 1/5

A patient feels only partial relief shortly after receiving Albuterol. What is the best interpretation?

  1. A.The medication has failed and should never be repeated
  2. B.No reassessment is needed because rescue medications work instantly
  3. C.The medication is a controller and requires several days to work
  4. D.Early improvement is expected, but full peak effect may take longer

Correct answer

Early improvement is expected, but full peak effect may take longer

Explanation

Albuterol begins working quickly, but peak effect may occur later. Early reassessment should consider timing, technique, dose, and severity.

Question 8Difficulty 1/5

A patient feels only partial relief shortly after receiving Albuterol. What is the best interpretation?

  1. A.The medication has failed and should never be repeated
  2. B.No reassessment is needed because rescue medications work instantly
  3. C.The medication is a controller and requires several days to work
  4. D.Early improvement is expected, but full peak effect may take longer

Correct answer

Early improvement is expected, but full peak effect may take longer

Explanation

Albuterol begins working quickly, but peak effect may occur later. Early reassessment should consider timing, technique, dose, and severity.

Question 9Difficulty 1/5

Which downstream effect follows the cAMP increase caused by Albuterol?

  1. A.Blocks muscarinic M3 receptors
  2. B.Provides exogenous surfactant
  3. C.Relaxes bronchial smooth muscle
  4. D.Activates protein kinase A downstream of cAMP

Correct answer

Activates protein kinase A downstream of cAMP

Explanation

Increased cAMP activates protein kinase A, contributing to smooth muscle relaxation.

Question 10Difficulty 1/5

Which mechanism explains why high-dose Albuterol can lower serum potassium?

  1. A.Inhibits phosphodiesterase-4
  2. B.Suppresses airway inflammation through glucocorticoid receptor activation
  3. C.Blocks leukotriene receptors
  4. D.Promotes intracellular potassium shift

Correct answer

Promotes intracellular potassium shift

Explanation

Beta-2 stimulation promotes intracellular potassium shift, which explains hypokalemia risk and off-label hyperkalemia use.

Question 11Difficulty 1/5

Which pharmacokinetic property makes Albuterol appropriate for acute bronchospasm?

  1. A.Intermediate onset with prolonged duration
  2. B.Delayed onset but 24-hour duration
  3. C.Requires several days for maximal bronchodilation
  4. D.Rapid onset of bronchodilation

Correct answer

Rapid onset of bronchodilation

Explanation

Rapid onset is why Albuterol is useful for acute bronchospasm.

Question 12Difficulty 1/5

What is the expected duration of bronchodilation from Albuterol?

  1. A.1 hour
  2. B.1–2 hours
  3. C.6–8 hours
  4. D.4 to 6 hours

Correct answer

4 to 6 hours

Explanation

Albuterol has a duration of about 4 to 6 hours, which is shorter than maintenance LABA/LAMA therapy.

Question 13Difficulty 1/5

An RT administers Albuterol for acute wheezing. When should bronchodilation typically begin?

  1. A.15–30 minutes
  2. B.Less than 1 minute
  3. C.30–60 minutes
  4. D.About 5 minutes

Correct answer

About 5 minutes

Explanation

Albuterol has a rapid onset of About 5 minutes, supporting its rescue role.

Question 14Difficulty 1/5

A patient reports no relief seconds after receiving Albuterol. What is the best RT interpretation?

  1. A.Assume the medication failed immediately
  2. B.Wait several days because bronchodilators require cumulative dosing
  3. C.Avoid reassessment because peak response is clinically irrelevant
  4. D.Reassess after enough time has passed for bronchodilation to occur

Correct answer

Reassess after enough time has passed for bronchodilation to occur

Explanation

Albuterol does not work instantly. Reassess after enough time for onset and response, while checking technique and severity.

Question 15Difficulty 2/5

What is the primary mechanism of action of Albuterol?

  1. A.Blocks cysteinyl leukotriene receptors
  2. B.Provides exogenous pulmonary surfactant
  3. C.Blocks muscarinic M3 receptors
  4. D.Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Correct answer

Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Explanation

Albuterol works by: Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Question 16Difficulty 2/5

For board exams, which mechanism should be associated with Albuterol?

  1. A.Blocks cysteinyl leukotriene receptors
  2. B.Suppresses airway inflammation through glucocorticoid receptor activation
  3. C.Produces selective pulmonary vasodilation via nitric oxide
  4. D.Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Correct answer

Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Explanation

Albuterol works by: Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Question 17Difficulty 2/5

A patient feels only partial relief shortly after receiving Albuterol. What is the best interpretation?

  1. A.The medication has failed and should never be repeated
  2. B.No reassessment is needed because rescue medications work instantly
  3. C.The medication is a controller and requires several days to work
  4. D.Early improvement is expected, but full peak effect may take longer

Correct answer

Early improvement is expected, but full peak effect may take longer

Explanation

Albuterol begins working quickly, but peak effect may occur later. Early reassessment should consider timing, technique, dose, and severity.

Question 18Difficulty 2/5

Which receptor action best explains how Albuterol relieves bronchospasm?

  1. A.Inhibits carbonic anhydrase
  2. B.Reduces intracellular calcium availability in airway smooth muscle
  3. C.Produces selective pulmonary vasodilation via nitric oxide
  4. D.Stimulates beta-2 adrenergic receptors

Correct answer

Stimulates beta-2 adrenergic receptors

Explanation

Albuterol is a short-acting beta-2 agonist that stimulates beta-2 receptors on airway smooth muscle.

Question 19Difficulty 2/5

Which mechanism belongs to an inhaled corticosteroid rather than Albuterol?

  1. A.Stimulates beta-2 adrenergic receptors
  2. B.Increases intracellular cAMP
  3. C.Promotes rapid bronchial smooth muscle relaxation
  4. D.Suppresses airway inflammation through glucocorticoid receptor activation

Correct answer

Suppresses airway inflammation through glucocorticoid receptor activation

Explanation

Inhaled corticosteroids reduce airway inflammation. Albuterol provides bronchodilation but is not an anti-inflammatory controller.

Question 20Difficulty 2/5

Which mechanism belongs to ipratropium rather than Albuterol?

  1. A.Stimulates beta-2 adrenergic receptors
  2. B.Increases intracellular cAMP
  3. C.Relaxes bronchial smooth muscle through beta-2 agonism
  4. D.Blocks muscarinic M3 receptors

Correct answer

Blocks muscarinic M3 receptors

Explanation

Ipratropium is a muscarinic antagonist. Albuterol is a beta-2 agonist.

Question 21Difficulty 2/5

Which mechanism best explains tachycardia or palpitations after repeated Albuterol treatments?

  1. A.Direct vagal blockade only
  2. B.Oropharyngeal fungal overgrowth
  3. C.Surfactant depletion
  4. D.Systemic beta stimulation and some cardiac beta receptor activity

Correct answer

Systemic beta stimulation and some cardiac beta receptor activity

Explanation

High doses or systemic absorption can produce cardiovascular beta-agonist effects, causing tachycardia or palpitations.

Question 22Difficulty 2/5

Which mechanism best explains tremor after Albuterol?

  1. A.Muscarinic receptor blockade in the bladder
  2. B.Glucocorticoid receptor activation in the airway
  3. C.Direct ototoxic injury to cranial nerve VIII
  4. D.Beta-2 stimulation in skeletal muscle

Correct answer

Beta-2 stimulation in skeletal muscle

Explanation

Tremor is caused by beta-2 stimulation in skeletal muscle, especially with higher doses.

Question 23Difficulty 2/5

Which timing profile best explains why Albuterol is a rescue medication rather than a controller?

  1. A.Slow onset with 24-hour duration
  2. B.Delayed onset requiring several days
  3. C.Long duration without rescue benefit
  4. D.Fast onset with short duration

Correct answer

Fast onset with short duration

Explanation

Albuterol works quickly but does not provide long-term anti-inflammatory control.

Question 24Difficulty 2/5

What is the intended airway smooth muscle effect of Albuterol?

  1. A.Blocks IgE-mediated allergic signaling
  2. B.Blocks leukotriene receptors
  3. C.Activates protein kinase A downstream of cAMP
  4. D.Relaxes bronchial smooth muscle

Correct answer

Relaxes bronchial smooth muscle

Explanation

The intended respiratory effect is bronchial smooth muscle relaxation and bronchodilation.

Question 25Difficulty 2/5

Which pharmacokinetic statement best differentiates Albuterol from long-acting maintenance bronchodilators?

  1. A.Albuterol has a 24-hour duration and is used once daily
  2. B.Albuterol is primarily an inhaled corticosteroid controller
  3. C.Albuterol has delayed onset and is not useful for acute symptoms
  4. D.Albuterol has a shorter duration and is used for rescue relief

Correct answer

Albuterol has a shorter duration and is used for rescue relief

Explanation

Albuterol has rapid onset and shorter duration; LABA/LAMA medications are designed for maintenance.

Question 26Difficulty 2/5

After beta-2 receptor stimulation by Albuterol, which intracellular messenger increases?

  1. A.Activates adenylyl cyclase through Gs signaling
  2. B.Provides exogenous surfactant
  3. C.Produces selective pulmonary vasodilation via nitric oxide
  4. D.Increases intracellular cAMP

Correct answer

Increases intracellular cAMP

Explanation

Beta-2 receptor stimulation activates Gs signaling and adenylyl cyclase, increasing cAMP.

Question 27Difficulty 2/5

A patient uses Albuterol before exercise-induced bronchospasm. Which timing concept explains this use?

  1. A.It must be started several days before exercise to become effective
  2. B.It lasts 24 hours after one rescue dose
  3. C.It prevents airway inflammation as a controller medication
  4. D.It can be used shortly before exertion because bronchodilation begins quickly

Correct answer

It can be used shortly before exertion because bronchodilation begins quickly

Explanation

Albuterol can be used before exertion because bronchodilation begins quickly and provides short-term symptom protection.

Question 28Difficulty 2/5

An RT administers Albuterol for acute wheezing. When should bronchodilation typically begin?

  1. A.Less than 1 minute
  2. B.Several hours
  3. C.15–30 minutes
  4. D.About 5 minutes

Correct answer

About 5 minutes

Explanation

Albuterol has a rapid onset of About 5 minutes, supporting its rescue role.

Question 29Difficulty 2/5

What is the expected duration of bronchodilation from Albuterol?

  1. A.12–24 hours
  2. B.1 hour
  3. C.1–2 hours
  4. D.4 to 6 hours

Correct answer

4 to 6 hours

Explanation

Albuterol has a duration of about 4 to 6 hours, which is shorter than maintenance LABA/LAMA therapy.

Question 30Difficulty 2/5

How does Albuterol produce its intended respiratory effect?

  1. A.Blocks muscarinic M3 receptors
  2. B.Produces selective pulmonary vasodilation via nitric oxide
  3. C.Inhibits carbonic anhydrase
  4. D.Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Correct answer

Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Explanation

Albuterol works by: Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Question 31Difficulty 3/5

Which downstream effect follows the cAMP increase caused by Albuterol?

  1. A.Increases intracellular cAMP
  2. B.Antagonizes endothelin receptors
  3. C.Hydrolyzes extracellular DNA in mucus
  4. D.Activates protein kinase A downstream of cAMP

Correct answer

Activates protein kinase A downstream of cAMP

Explanation

Increased cAMP activates protein kinase A, contributing to smooth muscle relaxation.

Question 32Difficulty 3/5

Which signaling pathway is most directly associated with beta-2 agonist activity from Albuterol?

  1. A.Activates protein kinase A downstream of cAMP
  2. B.Suppresses airway inflammation through glucocorticoid receptor activation
  3. C.May reduce mast-cell mediator release
  4. D.Activates adenylyl cyclase through Gs signaling

Correct answer

Activates adenylyl cyclase through Gs signaling

Explanation

Beta-2 receptors are Gs-coupled receptors that activate adenylyl cyclase and increase cAMP.

Question 33Difficulty 3/5

A patient feels only partial relief shortly after receiving Albuterol. What is the best interpretation?

  1. A.The medication has failed and should never be repeated
  2. B.No reassessment is needed because rescue medications work instantly
  3. C.The medication is a controller and requires several days to work
  4. D.Early improvement is expected, but full peak effect may take longer

Correct answer

Early improvement is expected, but full peak effect may take longer

Explanation

Albuterol begins working quickly, but peak effect may occur later. Early reassessment should consider timing, technique, dose, and severity.

Question 34Difficulty 3/5

A patient feels only partial relief shortly after receiving Albuterol. What is the best interpretation?

  1. A.The medication has failed and should never be repeated
  2. B.No reassessment is needed because rescue medications work instantly
  3. C.The medication is a controller and requires several days to work
  4. D.Early improvement is expected, but full peak effect may take longer

Correct answer

Early improvement is expected, but full peak effect may take longer

Explanation

Albuterol begins working quickly, but peak effect may occur later. Early reassessment should consider timing, technique, dose, and severity.

Question 35Difficulty 3/5

What is the primary mechanism of action of Albuterol?

  1. A.Hydrolyzes extracellular DNA reducing mucus viscosity
  2. B.Suppresses airway inflammation through glucocorticoid receptor activation
  3. C.Blocks IgE-mediated allergic signaling
  4. D.Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Correct answer

Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Explanation

Albuterol works by: Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Question 36Difficulty 3/5

An RT administers Albuterol. Which mechanism explains its effect?

  1. A.Hydrolyzes extracellular DNA reducing mucus viscosity
  2. B.Blocks cysteinyl leukotriene receptors
  3. C.Stimulates surfactant production
  4. D.Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Correct answer

Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Explanation

Albuterol works by: Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Question 37Difficulty 3/5

An RT administers Albuterol. Which mechanism explains its effect?

  1. A.Provides exogenous pulmonary surfactant
  2. B.Inhibits phosphodiesterase-4 increasing intracellular cAMP
  3. C.Suppresses airway inflammation through glucocorticoid receptor activation
  4. D.Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Correct answer

Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Explanation

Albuterol works by: Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Question 38Difficulty 3/5

An RT administers Albuterol for acute wheezing. When should bronchodilation typically begin?

  1. A.Several days
  2. B.1–2 hours
  3. C.Several hours
  4. D.About 5 minutes

Correct answer

About 5 minutes

Explanation

Albuterol has a rapid onset of About 5 minutes, supporting its rescue role.

Question 39Difficulty 3/5

A patient uses Albuterol before exercise-induced bronchospasm. Which timing concept explains this use?

  1. A.It must be started several days before exercise to become effective
  2. B.It lasts 24 hours after one rescue dose
  3. C.It prevents airway inflammation as a controller medication
  4. D.It can be used shortly before exertion because bronchodilation begins quickly

Correct answer

It can be used shortly before exertion because bronchodilation begins quickly

Explanation

Albuterol can be used before exertion because bronchodilation begins quickly and provides short-term symptom protection.

Question 40Difficulty 3/5

Which pharmacokinetic statement best differentiates Albuterol from long-acting maintenance bronchodilators?

  1. A.Albuterol has a 24-hour duration and is used once daily
  2. B.Albuterol is primarily an inhaled corticosteroid controller
  3. C.Albuterol has delayed onset and is not useful for acute symptoms
  4. D.Albuterol has a shorter duration and is used for rescue relief

Correct answer

Albuterol has a shorter duration and is used for rescue relief

Explanation

Albuterol has rapid onset and shorter duration; LABA/LAMA medications are designed for maintenance.

Question 41Difficulty 3/5

Which timing profile best explains why Albuterol is a rescue medication rather than a controller?

  1. A.Slow onset with 24-hour duration
  2. B.Delayed onset requiring several days
  3. C.Long duration without rescue benefit
  4. D.Fast onset with short duration

Correct answer

Fast onset with short duration

Explanation

Albuterol works quickly but does not provide long-term anti-inflammatory control.

Question 42Difficulty 3/5

A patient reports no relief seconds after receiving Albuterol. What is the best RT interpretation?

  1. A.Assume the medication failed immediately
  2. B.Wait several days because bronchodilators require cumulative dosing
  3. C.Avoid reassessment because peak response is clinically irrelevant
  4. D.Reassess after enough time has passed for bronchodilation to occur

Correct answer

Reassess after enough time has passed for bronchodilation to occur

Explanation

Albuterol does not work instantly. Reassess after enough time for onset and response, while checking technique and severity.

Question 43Difficulty 3/5

Which pharmacokinetic property makes Albuterol appropriate for acute bronchospasm?

  1. A.Intermediate onset with prolonged duration
  2. B.Slow onset intended for maintenance therapy
  3. C.Delayed onset but 24-hour duration
  4. D.Rapid onset of bronchodilation

Correct answer

Rapid onset of bronchodilation

Explanation

Rapid onset is why Albuterol is useful for acute bronchospasm.

Question 44Difficulty 3/5

Which mechanism belongs to an inhaled corticosteroid rather than Albuterol?

  1. A.Stimulates beta-2 adrenergic receptors
  2. B.Increases intracellular cAMP
  3. C.Promotes rapid bronchial smooth muscle relaxation
  4. D.Suppresses airway inflammation through glucocorticoid receptor activation

Correct answer

Suppresses airway inflammation through glucocorticoid receptor activation

Explanation

Inhaled corticosteroids reduce airway inflammation. Albuterol provides bronchodilation but is not an anti-inflammatory controller.

Question 45Difficulty 3/5

Which mechanism belongs to ipratropium rather than Albuterol?

  1. A.Stimulates beta-2 adrenergic receptors
  2. B.Increases intracellular cAMP
  3. C.Relaxes bronchial smooth muscle through beta-2 agonism
  4. D.Blocks muscarinic M3 receptors

Correct answer

Blocks muscarinic M3 receptors

Explanation

Ipratropium is a muscarinic antagonist. Albuterol is a beta-2 agonist.

Question 46Difficulty 3/5

Which mechanism best explains tachycardia or palpitations after repeated Albuterol treatments?

  1. A.Direct vagal blockade only
  2. B.Oropharyngeal fungal overgrowth
  3. C.Surfactant depletion
  4. D.Systemic beta stimulation and some cardiac beta receptor activity

Correct answer

Systemic beta stimulation and some cardiac beta receptor activity

Explanation

High doses or systemic absorption can produce cardiovascular beta-agonist effects, causing tachycardia or palpitations.

Question 47Difficulty 3/5

Which mechanism best explains tremor after Albuterol?

  1. A.Muscarinic receptor blockade in the bladder
  2. B.Glucocorticoid receptor activation in the airway
  3. C.Direct ototoxic injury to cranial nerve VIII
  4. D.Beta-2 stimulation in skeletal muscle

Correct answer

Beta-2 stimulation in skeletal muscle

Explanation

Tremor is caused by beta-2 stimulation in skeletal muscle, especially with higher doses.

Question 48Difficulty 3/5

Which mechanism explains why high-dose Albuterol can lower serum potassium?

  1. A.Blocks muscarinic M3 receptors
  2. B.Activates protein kinase A downstream of cAMP
  3. C.Inhibits phosphodiesterase-4
  4. D.Promotes intracellular potassium shift

Correct answer

Promotes intracellular potassium shift

Explanation

Beta-2 stimulation promotes intracellular potassium shift, which explains hypokalemia risk and off-label hyperkalemia use.

Question 49Difficulty 4/5

A patient feels only partial relief shortly after receiving Albuterol. What is the best interpretation?

  1. A.The medication has failed and should never be repeated
  2. B.No reassessment is needed because rescue medications work instantly
  3. C.The medication is a controller and requires several days to work
  4. D.Early improvement is expected, but full peak effect may take longer

Correct answer

Early improvement is expected, but full peak effect may take longer

Explanation

Albuterol begins working quickly, but peak effect may occur later. Early reassessment should consider timing, technique, dose, and severity.

Question 50Difficulty 4/5

What is the intended airway smooth muscle effect of Albuterol?

  1. A.Blocks muscarinic M3 receptors
  2. B.Provides exogenous surfactant
  3. C.Inhibits carbonic anhydrase
  4. D.Relaxes bronchial smooth muscle

Correct answer

Relaxes bronchial smooth muscle

Explanation

The intended respiratory effect is bronchial smooth muscle relaxation and bronchodilation.

Question 51Difficulty 4/5

What is the expected duration of bronchodilation from Albuterol?

  1. A.12 hours
  2. B.Several days
  3. C.2 hours
  4. D.4 to 6 hours

Correct answer

4 to 6 hours

Explanation

Albuterol has a duration of about 4 to 6 hours, which is shorter than maintenance LABA/LAMA therapy.

Question 52Difficulty 4/5

Which pharmacokinetic property makes Albuterol appropriate for acute bronchospasm?

  1. A.Intermediate onset with prolonged duration
  2. B.Requires several days for maximal bronchodilation
  3. C.Delayed onset but 24-hour duration
  4. D.Rapid onset of bronchodilation

Correct answer

Rapid onset of bronchodilation

Explanation

Rapid onset is why Albuterol is useful for acute bronchospasm.

Question 53Difficulty 4/5

A patient reports no relief seconds after receiving Albuterol. What is the best RT interpretation?

  1. A.Assume the medication failed immediately
  2. B.Wait several days because bronchodilators require cumulative dosing
  3. C.Avoid reassessment because peak response is clinically irrelevant
  4. D.Reassess after enough time has passed for bronchodilation to occur

Correct answer

Reassess after enough time has passed for bronchodilation to occur

Explanation

Albuterol does not work instantly. Reassess after enough time for onset and response, while checking technique and severity.

Question 54Difficulty 4/5

Which timing profile best explains why Albuterol is a rescue medication rather than a controller?

  1. A.Slow onset with 24-hour duration
  2. B.Delayed onset requiring several days
  3. C.Long duration without rescue benefit
  4. D.Fast onset with short duration

Correct answer

Fast onset with short duration

Explanation

Albuterol works quickly but does not provide long-term anti-inflammatory control.

Question 55Difficulty 4/5

Which pharmacokinetic statement best differentiates Albuterol from long-acting maintenance bronchodilators?

  1. A.Albuterol has a 24-hour duration and is used once daily
  2. B.Albuterol is primarily an inhaled corticosteroid controller
  3. C.Albuterol has delayed onset and is not useful for acute symptoms
  4. D.Albuterol has a shorter duration and is used for rescue relief

Correct answer

Albuterol has a shorter duration and is used for rescue relief

Explanation

Albuterol has rapid onset and shorter duration; LABA/LAMA medications are designed for maintenance.

Question 56Difficulty 4/5

Which signaling pathway is most directly associated with beta-2 agonist activity from Albuterol?

  1. A.Provides exogenous surfactant
  2. B.May reduce mast-cell mediator release
  3. C.Suppresses airway inflammation through glucocorticoid receptor activation
  4. D.Activates adenylyl cyclase through Gs signaling

Correct answer

Activates adenylyl cyclase through Gs signaling

Explanation

Beta-2 receptors are Gs-coupled receptors that activate adenylyl cyclase and increase cAMP.

Question 57Difficulty 4/5

After beta-2 receptor stimulation by Albuterol, which intracellular messenger increases?

  1. A.Reduces intracellular calcium availability in airway smooth muscle
  2. B.Antagonizes endothelin receptors
  3. C.Activates protein kinase A downstream of cAMP
  4. D.Increases intracellular cAMP

Correct answer

Increases intracellular cAMP

Explanation

Beta-2 receptor stimulation activates Gs signaling and adenylyl cyclase, increasing cAMP.

Question 58Difficulty 4/5

Which receptor action best explains how Albuterol relieves bronchospasm?

  1. A.Activates adenylyl cyclase through Gs signaling
  2. B.Reduces intracellular calcium availability in airway smooth muscle
  3. C.Blocks IgE-mediated allergic signaling
  4. D.Stimulates beta-2 adrenergic receptors

Correct answer

Stimulates beta-2 adrenergic receptors

Explanation

Albuterol is a short-acting beta-2 agonist that stimulates beta-2 receptors on airway smooth muscle.

Question 59Difficulty 4/5

Albuterol works primarily through which mechanism?

  1. A.Hydrolyzes extracellular DNA reducing mucus viscosity
  2. B.Inhibits phosphodiesterase-4 increasing intracellular cAMP
  3. C.Inhibits phosphodiesterase causing bronchodilation
  4. D.Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Correct answer

Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Explanation

Albuterol works by: Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Question 60Difficulty 4/5

Which mechanism should a student recognize for Albuterol?

  1. A.Blocks muscarinic M3 receptors
  2. B.Suppresses airway inflammation through glucocorticoid receptor activation
  3. C.Blocks IgE-mediated allergic signaling
  4. D.Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Correct answer

Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Explanation

Albuterol works by: Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Question 61Difficulty 4/5

Which pharmacologic action is most consistent with Albuterol?

  1. A.Suppresses airway inflammation through glucocorticoid receptor activation
  2. B.Produces selective pulmonary vasodilation via nitric oxide
  3. C.Blocks muscarinic M3 receptors
  4. D.Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Correct answer

Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Explanation

Albuterol works by: Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Question 62Difficulty 4/5

Which downstream effect follows the cAMP increase caused by Albuterol?

  1. A.Blocks IgE-mediated allergic signaling
  2. B.Relaxes bronchial smooth muscle
  3. C.Activates adenylyl cyclase through Gs signaling
  4. D.Activates protein kinase A downstream of cAMP

Correct answer

Activates protein kinase A downstream of cAMP

Explanation

Increased cAMP activates protein kinase A, contributing to smooth muscle relaxation.

Question 63Difficulty 4/5

Which mechanism explains why high-dose Albuterol can lower serum potassium?

  1. A.Blocks muscarinic M3 receptors
  2. B.Increases intracellular cAMP
  3. C.Suppresses airway inflammation through glucocorticoid receptor activation
  4. D.Promotes intracellular potassium shift

Correct answer

Promotes intracellular potassium shift

Explanation

Beta-2 stimulation promotes intracellular potassium shift, which explains hypokalemia risk and off-label hyperkalemia use.

Question 64Difficulty 4/5

Which mechanism best explains tremor after Albuterol?

  1. A.Muscarinic receptor blockade in the bladder
  2. B.Glucocorticoid receptor activation in the airway
  3. C.Direct ototoxic injury to cranial nerve VIII
  4. D.Beta-2 stimulation in skeletal muscle

Correct answer

Beta-2 stimulation in skeletal muscle

Explanation

Tremor is caused by beta-2 stimulation in skeletal muscle, especially with higher doses.

Question 65Difficulty 5/5

How does Albuterol produce its intended respiratory effect?

  1. A.Hydrolyzes extracellular DNA reducing mucus viscosity
  2. B.Blocks muscarinic M3 receptors
  3. C.Produces selective pulmonary vasodilation via nitric oxide
  4. D.Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Correct answer

Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Explanation

Albuterol works by: Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Question 66Difficulty 5/5

Which pharmacologic action is most consistent with Albuterol?

  1. A.Blocks IgE-mediated allergic signaling
  2. B.Inhibits endothelin receptors
  3. C.Suppresses airway inflammation through glucocorticoid receptor activation
  4. D.Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Correct answer

Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Explanation

Albuterol works by: Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Question 67Difficulty 5/5

Which pharmacologic action is most consistent with Albuterol?

  1. A.Provides exogenous pulmonary surfactant
  2. B.Hydrolyzes extracellular DNA reducing mucus viscosity
  3. C.Blocks muscarinic M3 receptors
  4. D.Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Correct answer

Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Explanation

Albuterol works by: Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Question 68Difficulty 5/5

How does Albuterol produce its intended respiratory effect?

  1. A.Inhibits carbonic anhydrase
  2. B.Suppresses airway inflammation through glucocorticoid receptor activation
  3. C.Blocks cysteinyl leukotriene receptors
  4. D.Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Correct answer

Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Explanation

Albuterol works by: Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Question 69Difficulty 5/5

Which pharmacologic action is most consistent with Albuterol?

  1. A.Suppresses airway inflammation through glucocorticoid receptor activation
  2. B.Inhibits phosphodiesterase causing bronchodilation
  3. C.Inhibits phosphodiesterase-4 increasing intracellular cAMP
  4. D.Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Correct answer

Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Explanation

Albuterol works by: Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Question 70Difficulty 5/5

For board exams, which mechanism should be associated with Albuterol?

  1. A.Provides exogenous pulmonary surfactant
  2. B.Produces selective pulmonary vasodilation via nitric oxide
  3. C.Inhibits endothelin receptors
  4. D.Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Correct answer

Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Explanation

Albuterol works by: Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Question 71Difficulty 5/5

Albuterol works primarily through which mechanism?

  1. A.Breaks disulfide bonds within mucus
  2. B.Suppresses airway inflammation through glucocorticoid receptor activation
  3. C.Inhibits phosphodiesterase causing bronchodilation
  4. D.Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Correct answer

Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Explanation

Albuterol works by: Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Question 72Difficulty 5/5

Which mechanism belongs to an inhaled corticosteroid rather than Albuterol?

  1. A.Stimulates beta-2 adrenergic receptors
  2. B.Increases intracellular cAMP
  3. C.Promotes rapid bronchial smooth muscle relaxation
  4. D.Suppresses airway inflammation through glucocorticoid receptor activation

Correct answer

Suppresses airway inflammation through glucocorticoid receptor activation

Explanation

Inhaled corticosteroids reduce airway inflammation. Albuterol provides bronchodilation but is not an anti-inflammatory controller.

Question 73Difficulty 5/5

A patient uses Albuterol before exercise-induced bronchospasm. Which timing concept explains this use?

  1. A.It must be started several days before exercise to become effective
  2. B.It lasts 24 hours after one rescue dose
  3. C.It prevents airway inflammation as a controller medication
  4. D.It can be used shortly before exertion because bronchodilation begins quickly

Correct answer

It can be used shortly before exertion because bronchodilation begins quickly

Explanation

Albuterol can be used before exertion because bronchodilation begins quickly and provides short-term symptom protection.

Question 74Difficulty 5/5

After beta-2 receptor stimulation by Albuterol, which intracellular messenger increases?

  1. A.Blocks muscarinic M3 receptors
  2. B.Stimulates beta-2 adrenergic receptors
  3. C.Blocks IgE-mediated allergic signaling
  4. D.Increases intracellular cAMP

Correct answer

Increases intracellular cAMP

Explanation

Beta-2 receptor stimulation activates Gs signaling and adenylyl cyclase, increasing cAMP.

Question 75Difficulty 5/5

Which receptor action best explains how Albuterol relieves bronchospasm?

  1. A.Reduces intracellular calcium availability in airway smooth muscle
  2. B.Blocks leukotriene receptors
  3. C.May reduce mast-cell mediator release
  4. D.Stimulates beta-2 adrenergic receptors

Correct answer

Stimulates beta-2 adrenergic receptors

Explanation

Albuterol is a short-acting beta-2 agonist that stimulates beta-2 receptors on airway smooth muscle.

Question 76Difficulty 5/5

A patient feels only partial relief shortly after receiving Albuterol. What is the best interpretation?

  1. A.The medication has failed and should never be repeated
  2. B.No reassessment is needed because rescue medications work instantly
  3. C.The medication is a controller and requires several days to work
  4. D.Early improvement is expected, but full peak effect may take longer

Correct answer

Early improvement is expected, but full peak effect may take longer

Explanation

Albuterol begins working quickly, but peak effect may occur later. Early reassessment should consider timing, technique, dose, and severity.

Question 77Difficulty 5/5

A patient feels only partial relief shortly after receiving Albuterol. What is the best interpretation?

  1. A.The medication has failed and should never be repeated
  2. B.No reassessment is needed because rescue medications work instantly
  3. C.The medication is a controller and requires several days to work
  4. D.Early improvement is expected, but full peak effect may take longer

Correct answer

Early improvement is expected, but full peak effect may take longer

Explanation

Albuterol begins working quickly, but peak effect may occur later. Early reassessment should consider timing, technique, dose, and severity.

Question 78Difficulty 5/5

Which mechanism best explains tachycardia or palpitations after repeated Albuterol treatments?

  1. A.Direct vagal blockade only
  2. B.Oropharyngeal fungal overgrowth
  3. C.Surfactant depletion
  4. D.Systemic beta stimulation and some cardiac beta receptor activity

Correct answer

Systemic beta stimulation and some cardiac beta receptor activity

Explanation

High doses or systemic absorption can produce cardiovascular beta-agonist effects, causing tachycardia or palpitations.

Question 79Difficulty 5/5

Which mechanism belongs to ipratropium rather than Albuterol?

  1. A.Stimulates beta-2 adrenergic receptors
  2. B.Increases intracellular cAMP
  3. C.Relaxes bronchial smooth muscle through beta-2 agonism
  4. D.Blocks muscarinic M3 receptors

Correct answer

Blocks muscarinic M3 receptors

Explanation

Ipratropium is a muscarinic antagonist. Albuterol is a beta-2 agonist.

Question 80Difficulty 5/5

Which pharmacologic action is most consistent with Albuterol?

  1. A.Stimulates surfactant production
  2. B.Blocks cysteinyl leukotriene receptors
  3. C.Inhibits phosphodiesterase causing bronchodilation
  4. D.Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Correct answer

Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Explanation

Albuterol works by: Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Question 81Difficulty 5/5

Which pharmacologic action is most consistent with Albuterol?

  1. A.Stimulates soluble guanylate cyclase
  2. B.Hydrolyzes extracellular DNA reducing mucus viscosity
  3. C.Stimulates surfactant production
  4. D.Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Correct answer

Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Explanation

Albuterol works by: Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation.

Question group

Indications and Clinical Use

44 questions
Question 1Difficulty 1/5

Which device teaching point is correct for a dry powder formulation of Albuterol?

  1. A.Dry powder inhaler requires no patient effort
  2. B.Dry powder inhaler is administered through an IV pump
  3. C.Dry powder inhaler is preferred for unconscious patients
  4. D.Dry powder inhaler requires adequate inspiratory flow

Correct answer

Dry powder inhaler requires adequate inspiratory flow

Explanation

Dry powder inhalers require adequate inspiratory flow and are not ideal for patients unable to inhale forcefully.

Question 2Difficulty 1/5

For board exams, which indication should be associated with Albuterol?

  1. A.Obstructive sleep apnea
  2. B.Pulmonary embolism
  3. C.Idiopathic pulmonary fibrosis
  4. D.Exercise-induced bronchospasm prevention

Correct answer

Exercise-induced bronchospasm prevention

Explanation

Albuterol is used for: Exercise-induced bronchospasm prevention. The other options are not primary indications for this medication.

Question 3Difficulty 1/5

Which clinical use is appropriate for Albuterol?

  1. A.Maintenance treatment of persistent asthma
  2. B.Pulmonary embolism
  3. C.Idiopathic pulmonary fibrosis
  4. D.COPD exacerbation

Correct answer

COPD exacerbation

Explanation

Albuterol is used for: COPD exacerbation. The other options are not primary indications for this medication.

Question 4Difficulty 1/5

Which delivery device is commonly used to administer Albuterol?

  1. A.Sublingual tablet
  2. B.Ophthalmic drops
  3. C.Transdermal patch
  4. D.MDI

Correct answer

MDI

Explanation

Albuterol can be administered using devices such as MDI, Nebulizer, DPI depending on formulation.

Question 5Difficulty 1/5

Which route is appropriate for Albuterol?

  1. A.Transdermal patch
  2. B.Intranasal spray
  3. C.Sublingual tablet
  4. D.Inhalation

Correct answer

Inhalation

Explanation

Albuterol is commonly administered by these routes: Inhalation.

Question 6Difficulty 1/5

A coordinated adult patient needs rapid bronchodilator therapy. Which device setup is appropriate for Albuterol?

  1. A.Transdermal patch
  2. B.Rectal suppository
  3. C.Ophthalmic drops
  4. D.Pressurized metered-dose inhaler with spacer

Correct answer

Pressurized metered-dose inhaler with spacer

Explanation

A pressurized MDI with spacer is an effective delivery setup for rapid bronchodilator administration when technique is adequate.

Question 7Difficulty 1/5

A dyspneic patient cannot coordinate inhaler technique. Which delivery device is most appropriate for Albuterol?

  1. A.Ophthalmic drops
  2. B.Transdermal patch
  3. C.Rectal suppository
  4. D.Small-volume nebulizer

Correct answer

Small-volume nebulizer

Explanation

A small-volume nebulizer is useful when the patient cannot coordinate MDI technique.

Question 8Difficulty 1/5

Which clinical use is appropriate for Albuterol?

  1. A.Cystic fibrosis mucus clearance
  2. B.Obstructive sleep apnea
  3. C.Anaphylaxis
  4. D.Acute bronchospasm

Correct answer

Acute bronchospasm

Explanation

Albuterol is used for: Acute bronchospasm. The other options are not primary indications for this medication.

Question 9Difficulty 2/5

Which route is appropriate for Albuterol?

  1. A.Dry powder inhaler
  2. B.Pressurized metered-dose inhaler
  3. C.Sublingual tablet
  4. D.Inhalation

Correct answer

Inhalation

Explanation

Albuterol is commonly administered by these routes: Inhalation.

Question 10Difficulty 2/5

A coordinated adult patient needs rapid bronchodilator therapy. Which device setup is appropriate for Albuterol?

  1. A.Transdermal patch
  2. B.Rectal suppository
  3. C.Ophthalmic drops
  4. D.Pressurized metered-dose inhaler with spacer

Correct answer

Pressurized metered-dose inhaler with spacer

Explanation

A pressurized MDI with spacer is an effective delivery setup for rapid bronchodilator administration when technique is adequate.

Question 11Difficulty 2/5

Which use is most consistent with Albuterol?

  1. A.Maintenance treatment of COPD
  2. B.Persistent allergic rhinitis
  3. C.Pulmonary alveolar proteinosis
  4. D.Exercise-induced bronchospasm prevention

Correct answer

Exercise-induced bronchospasm prevention

Explanation

Albuterol is used for: Exercise-induced bronchospasm prevention. The other options are not primary indications for this medication.

Question 12Difficulty 2/5

A provider orders Albuterol. Which indication best supports this order?

  1. A.Alpha-1 antitrypsin deficiency
  2. B.Acute respiratory distress syndrome
  3. C.Upper airway edema
  4. D.COPD exacerbation

Correct answer

COPD exacerbation

Explanation

Albuterol is used for: COPD exacerbation. The other options are not primary indications for this medication.

Question 13Difficulty 2/5

Which use is most consistent with Albuterol?

  1. A.Cystic fibrosis mucus clearance
  2. B.Pulmonary alveolar proteinosis
  3. C.Pulmonary arterial hypertension
  4. D.Exercise-induced bronchospasm prevention

Correct answer

Exercise-induced bronchospasm prevention

Explanation

Albuterol is used for: Exercise-induced bronchospasm prevention. The other options are not primary indications for this medication.

Question 14Difficulty 2/5

A provider orders Albuterol. Which indication best supports this order?

  1. A.Acute bacterial pneumonia
  2. B.Acute cardiogenic pulmonary edema
  3. C.Primary ciliary dyskinesia
  4. D.COPD exacerbation

Correct answer

COPD exacerbation

Explanation

Albuterol is used for: COPD exacerbation. The other options are not primary indications for this medication.

Question 15Difficulty 2/5

How can Albuterol be delivered to an intubated mechanically ventilated patient?

  1. A.Remove the endotracheal tube for each treatment
  2. B.Administer as ophthalmic drops
  3. C.Use a transdermal bronchodilator patch
  4. D.Use an inline nebulizer or MDI adapter in the ventilator circuit

Correct answer

Use an inline nebulizer or MDI adapter in the ventilator circuit

Explanation

Bronchodilators can be delivered in ventilator circuits using an inline nebulizer or MDI adapter.

Question 16Difficulty 2/5

Why might an RT recommend a spacer with Albuterol MDI therapy?

  1. A.A spacer converts albuterol into a corticosteroid
  2. B.A spacer eliminates the need to inhale
  3. C.A spacer is only used for oral tablets
  4. D.A spacer helps improve aerosol delivery and reduce coordination problems

Correct answer

A spacer helps improve aerosol delivery and reduce coordination problems

Explanation

A spacer or valved holding chamber can improve aerosol delivery and reduce hand-breath coordination problems.

Question 17Difficulty 2/5

Which statement best compares MDI-spacer delivery and nebulized delivery for Albuterol?

  1. A.Nebulizer is always superior regardless of technique
  2. B.MDI therapy is never effective for bronchodilation
  3. C.Only oral tablets work for acute bronchospasm
  4. D.Nebulizer or MDI with spacer can both be appropriate depending on patient ability

Correct answer

Nebulizer or MDI with spacer can both be appropriate depending on patient ability

Explanation

Both nebulizer and MDI-spacer delivery can be effective; device selection depends on patient coordination, severity, setting, and available equipment.

Question 18Difficulty 2/5

Which delivery device is commonly used to administer Albuterol?

  1. A.Intranasal spray
  2. B.Endotracheal tube during mechanical ventilation
  3. C.Transdermal patch
  4. D.MDI

Correct answer

MDI

Explanation

Albuterol can be administered using devices such as MDI, Nebulizer, DPI depending on formulation.

Question 19Difficulty 3/5

Which clinical use is appropriate for Albuterol?

  1. A.Idiopathic pulmonary fibrosis
  2. B.Obstructive sleep apnea
  3. C.Maintenance treatment of persistent asthma
  4. D.Exercise-induced bronchospasm prevention

Correct answer

Exercise-induced bronchospasm prevention

Explanation

Albuterol is used for: Exercise-induced bronchospasm prevention. The other options are not primary indications for this medication.

Question 20Difficulty 3/5

An RT is reviewing indications for Albuterol. Which option is correct?

  1. A.Acute respiratory distress syndrome
  2. B.Persistent allergic rhinitis
  3. C.Idiopathic pulmonary fibrosis
  4. D.Exercise-induced bronchospasm prevention

Correct answer

Exercise-induced bronchospasm prevention

Explanation

Albuterol is used for: Exercise-induced bronchospasm prevention. The other options are not primary indications for this medication.

Question 21Difficulty 3/5

Which delivery device is commonly used to administer Albuterol?

  1. A.Ophthalmic drops
  2. B.Oral tablet or syrup
  3. C.Rectal suppository
  4. D.MDI

Correct answer

MDI

Explanation

Albuterol can be administered using devices such as MDI, Nebulizer, DPI depending on formulation.

Question 22Difficulty 3/5

Which statement best compares MDI-spacer delivery and nebulized delivery for Albuterol?

  1. A.Nebulizer is always superior regardless of technique
  2. B.MDI therapy is never effective for bronchodilation
  3. C.Only oral tablets work for acute bronchospasm
  4. D.Nebulizer or MDI with spacer can both be appropriate depending on patient ability

Correct answer

Nebulizer or MDI with spacer can both be appropriate depending on patient ability

Explanation

Both nebulizer and MDI-spacer delivery can be effective; device selection depends on patient coordination, severity, setting, and available equipment.

Question 23Difficulty 3/5

Why might an RT recommend a spacer with Albuterol MDI therapy?

  1. A.A spacer converts albuterol into a corticosteroid
  2. B.A spacer eliminates the need to inhale
  3. C.A spacer is only used for oral tablets
  4. D.A spacer helps improve aerosol delivery and reduce coordination problems

Correct answer

A spacer helps improve aerosol delivery and reduce coordination problems

Explanation

A spacer or valved holding chamber can improve aerosol delivery and reduce hand-breath coordination problems.

Question 24Difficulty 3/5

How can Albuterol be delivered to an intubated mechanically ventilated patient?

  1. A.Remove the endotracheal tube for each treatment
  2. B.Administer as ophthalmic drops
  3. C.Use a transdermal bronchodilator patch
  4. D.Use an inline nebulizer or MDI adapter in the ventilator circuit

Correct answer

Use an inline nebulizer or MDI adapter in the ventilator circuit

Explanation

Bronchodilators can be delivered in ventilator circuits using an inline nebulizer or MDI adapter.

Question 25Difficulty 3/5

Which device teaching point is correct for a dry powder formulation of Albuterol?

  1. A.Dry powder inhaler requires no patient effort
  2. B.Dry powder inhaler is administered through an IV pump
  3. C.Dry powder inhaler is preferred for unconscious patients
  4. D.Dry powder inhaler requires adequate inspiratory flow

Correct answer

Dry powder inhaler requires adequate inspiratory flow

Explanation

Dry powder inhalers require adequate inspiratory flow and are not ideal for patients unable to inhale forcefully.

Question 26Difficulty 3/5

A dyspneic patient cannot coordinate inhaler technique. Which delivery device is most appropriate for Albuterol?

  1. A.Ophthalmic drops
  2. B.Transdermal patch
  3. C.Rectal suppository
  4. D.Small-volume nebulizer

Correct answer

Small-volume nebulizer

Explanation

A small-volume nebulizer is useful when the patient cannot coordinate MDI technique.

Question 27Difficulty 3/5

Which patient scenario is most appropriate for Albuterol?

  1. A.Anaphylaxis
  2. B.Non-CF bronchiectasis
  3. C.Acute cardiogenic pulmonary edema
  4. D.Asthma exacerbation

Correct answer

Asthma exacerbation

Explanation

Albuterol is used for: Asthma exacerbation. The other options are not primary indications for this medication.

Question 28Difficulty 3/5

For board exams, which indication should be associated with Albuterol?

  1. A.Acute respiratory distress syndrome
  2. B.Pulmonary alveolar proteinosis
  3. C.Anaphylaxis
  4. D.Asthma exacerbation

Correct answer

Asthma exacerbation

Explanation

Albuterol is used for: Asthma exacerbation. The other options are not primary indications for this medication.

Question 29Difficulty 4/5

A dyspneic patient cannot coordinate inhaler technique. Which delivery device is most appropriate for Albuterol?

  1. A.Ophthalmic drops
  2. B.Transdermal patch
  3. C.Rectal suppository
  4. D.Small-volume nebulizer

Correct answer

Small-volume nebulizer

Explanation

A small-volume nebulizer is useful when the patient cannot coordinate MDI technique.

Question 30Difficulty 4/5

Why might an RT recommend a spacer with Albuterol MDI therapy?

  1. A.A spacer converts albuterol into a corticosteroid
  2. B.A spacer eliminates the need to inhale
  3. C.A spacer is only used for oral tablets
  4. D.A spacer helps improve aerosol delivery and reduce coordination problems

Correct answer

A spacer helps improve aerosol delivery and reduce coordination problems

Explanation

A spacer or valved holding chamber can improve aerosol delivery and reduce hand-breath coordination problems.

Question 31Difficulty 4/5

Which route is appropriate for Albuterol?

  1. A.Dry powder inhaler
  2. B.High-flow nasal cannula with inline nebulizer
  3. C.Intravenous infusion
  4. D.Inhalation

Correct answer

Inhalation

Explanation

Albuterol is commonly administered by these routes: Inhalation.

Question 32Difficulty 4/5

How can Albuterol be delivered to an intubated mechanically ventilated patient?

  1. A.Remove the endotracheal tube for each treatment
  2. B.Administer as ophthalmic drops
  3. C.Use a transdermal bronchodilator patch
  4. D.Use an inline nebulizer or MDI adapter in the ventilator circuit

Correct answer

Use an inline nebulizer or MDI adapter in the ventilator circuit

Explanation

Bronchodilators can be delivered in ventilator circuits using an inline nebulizer or MDI adapter.

Question 33Difficulty 4/5

Which device teaching point is correct for a dry powder formulation of Albuterol?

  1. A.Dry powder inhaler requires no patient effort
  2. B.Dry powder inhaler is administered through an IV pump
  3. C.Dry powder inhaler is preferred for unconscious patients
  4. D.Dry powder inhaler requires adequate inspiratory flow

Correct answer

Dry powder inhaler requires adequate inspiratory flow

Explanation

Dry powder inhalers require adequate inspiratory flow and are not ideal for patients unable to inhale forcefully.

Question 34Difficulty 4/5

Which condition best matches the use of Albuterol?

  1. A.Pulmonary arterial hypertension
  2. B.Cystic fibrosis mucus clearance
  3. C.Pulmonary embolism
  4. D.COPD exacerbation

Correct answer

COPD exacerbation

Explanation

Albuterol is used for: COPD exacerbation. The other options are not primary indications for this medication.

Question 35Difficulty 4/5

Which patient scenario is most appropriate for Albuterol?

  1. A.Upper airway edema
  2. B.Anaphylaxis
  3. C.Bronchiolitis
  4. D.Acute bronchospasm

Correct answer

Acute bronchospasm

Explanation

Albuterol is used for: Acute bronchospasm. The other options are not primary indications for this medication.

Question 36Difficulty 4/5

Which condition best matches the use of Albuterol?

  1. A.Maintenance treatment of COPD
  2. B.Neonatal respiratory distress syndrome
  3. C.Maintenance treatment of persistent asthma
  4. D.Asthma exacerbation

Correct answer

Asthma exacerbation

Explanation

Albuterol is used for: Asthma exacerbation. The other options are not primary indications for this medication.

Question 37Difficulty 4/5

Which use is most consistent with Albuterol?

  1. A.Primary ciliary dyskinesia
  2. B.Cystic fibrosis mucus clearance
  3. C.Obstructive sleep apnea
  4. D.Asthma exacerbation

Correct answer

Asthma exacerbation

Explanation

Albuterol is used for: Asthma exacerbation. The other options are not primary indications for this medication.

Question 38Difficulty 4/5

A coordinated adult patient needs rapid bronchodilator therapy. Which device setup is appropriate for Albuterol?

  1. A.Transdermal patch
  2. B.Rectal suppository
  3. C.Ophthalmic drops
  4. D.Pressurized metered-dose inhaler with spacer

Correct answer

Pressurized metered-dose inhaler with spacer

Explanation

A pressurized MDI with spacer is an effective delivery setup for rapid bronchodilator administration when technique is adequate.

Question 39Difficulty 5/5

Which patient scenario is most appropriate for Albuterol?

  1. A.Maintenance treatment of COPD
  2. B.Pulmonary embolism
  3. C.Idiopathic pulmonary fibrosis
  4. D.Acute bronchospasm

Correct answer

Acute bronchospasm

Explanation

Albuterol is used for: Acute bronchospasm. The other options are not primary indications for this medication.

Question 40Difficulty 5/5

Which statement best compares MDI-spacer delivery and nebulized delivery for Albuterol?

  1. A.Nebulizer is always superior regardless of technique
  2. B.MDI therapy is never effective for bronchodilation
  3. C.Only oral tablets work for acute bronchospasm
  4. D.Nebulizer or MDI with spacer can both be appropriate depending on patient ability

Correct answer

Nebulizer or MDI with spacer can both be appropriate depending on patient ability

Explanation

Both nebulizer and MDI-spacer delivery can be effective; device selection depends on patient coordination, severity, setting, and available equipment.

Question 41Difficulty 5/5

Albuterol is commonly used for which indication?

  1. A.Non-CF bronchiectasis
  2. B.Persistent allergic rhinitis
  3. C.Maintenance treatment of COPD
  4. D.COPD exacerbation

Correct answer

COPD exacerbation

Explanation

Albuterol is used for: COPD exacerbation. The other options are not primary indications for this medication.

Question 42Difficulty 5/5

A provider orders Albuterol. Which indication best supports this order?

  1. A.Interstitial lung disease
  2. B.Anaphylaxis
  3. C.Maintenance treatment of persistent asthma
  4. D.Exercise-induced bronchospasm prevention

Correct answer

Exercise-induced bronchospasm prevention

Explanation

Albuterol is used for: Exercise-induced bronchospasm prevention. The other options are not primary indications for this medication.

Question 43Difficulty 5/5

For board exams, which indication should be associated with Albuterol?

  1. A.Bronchiolitis
  2. B.Pulmonary arterial hypertension
  3. C.Acute bacterial pneumonia
  4. D.Exercise-induced bronchospasm prevention

Correct answer

Exercise-induced bronchospasm prevention

Explanation

Albuterol is used for: Exercise-induced bronchospasm prevention. The other options are not primary indications for this medication.

Question 44Difficulty 5/5

For board exams, which indication should be associated with Albuterol?

  1. A.Anaphylaxis
  2. B.Alpha-1 antitrypsin deficiency
  3. C.Primary ciliary dyskinesia
  4. D.Asthma exacerbation

Correct answer

Asthma exacerbation

Explanation

Albuterol is used for: Asthma exacerbation. The other options are not primary indications for this medication.

Question group

Contraindications, Safety, and Interactions

44 questions
Question 1Difficulty 1/5

Which patient could safely receive Albuterol?

  1. A.Milk protein allergy with certain dry powder inhalers
  2. B.Hypersensitivity to albuterol or formulation components
  3. C.Recent myocardial infarction with unstable arrhythmias
  4. D.Controlled hyperthyroidism

Correct answer

Controlled hyperthyroidism

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 2Difficulty 1/5

Which finding should make the RT withhold Albuterol and notify the provider?

  1. A.Milk protein allergy with certain dry powder inhalers
  2. B.History of severe immediate allergic reaction to albuterol
  3. C.Use of non-selective beta blockers
  4. D.Hypersensitivity to albuterol or formulation components

Correct answer

Hypersensitivity to albuterol or formulation components

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 3Difficulty 1/5

Which patient could safely receive Albuterol?

  1. A.Milk protein allergy with certain dry powder inhalers
  2. B.Hypersensitivity to albuterol or formulation components
  3. C.Known paradoxical bronchospasm after previous albuterol treatment
  4. D.Well-controlled atrial fibrillation

Correct answer

Well-controlled atrial fibrillation

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 4Difficulty 1/5

Which medication class can potentiate cardiovascular effects from Albuterol?

  1. A.Inhaled corticosteroids
  2. B.Mucolytics
  3. C.Leukotriene receptor antagonists
  4. D.Monoamine oxidase inhibitors (MAOIs)

Correct answer

Monoamine oxidase inhibitors (MAOIs)

Explanation

MAOIs can potentiate adrenergic cardiovascular effects from beta agonists.

Question 5Difficulty 1/5

Which medication class increases concern for hypokalemia when combined with frequent Albuterol?

  1. A.Inhaled corticosteroids
  2. B.Mucolytics
  3. C.Antitussives
  4. D.Loop diuretics

Correct answer

Loop diuretics

Explanation

Loop diuretics can lower potassium, and beta-2 agonists can shift potassium intracellularly.

Question 6Difficulty 1/5

Which medication group may increase cardiovascular stimulation when combined with Albuterol?

  1. A.Inhaled corticosteroids
  2. B.Anticholinergic bronchodilators
  3. C.Mucolytics
  4. D.Other sympathomimetic medications

Correct answer

Other sympathomimetic medications

Explanation

Combining sympathomimetics can increase tachycardia, palpitations, tremor, and blood pressure effects.

Question 7Difficulty 1/5

Which medication class may reduce the bronchodilator effect of Albuterol?

  1. A.Loop diuretics
  2. B.Digoxin
  3. C.Caffeine
  4. D.Non-selective beta blockers

Correct answer

Non-selective beta blockers

Explanation

Non-selective beta blockers can blunt beta-2 bronchodilation and may worsen bronchospasm.

Question 8Difficulty 2/5

A COPD patient taking propranolol has minimal response to repeated Albuterol. What is the best explanation?

  1. A.Inhaled corticosteroids block all beta-2 receptors
  2. B.Spacer use prevents bronchodilation
  3. C.Loop diuretics directly block airway beta receptors
  4. D.Non-selective beta blocker use may blunt the response

Correct answer

Non-selective beta blocker use may blunt the response

Explanation

Propranolol is a non-selective beta blocker and can oppose beta-2 agonist bronchodilation.

Question 9Difficulty 2/5

A patient on an MAOI develops worsening tachycardia after repeated Albuterol. What is the best interpretation?

  1. A.The interaction prevents all bronchodilation
  2. B.The combination eliminates tachycardia risk
  3. C.The finding is unrelated to adrenergic stimulation
  4. D.The interaction may potentiate sympathomimetic cardiovascular effects

Correct answer

The interaction may potentiate sympathomimetic cardiovascular effects

Explanation

MAOIs may potentiate cardiovascular responses to adrenergic medications.

Question 10Difficulty 2/5

Which drug class may increase cardiovascular sensitivity to Albuterol?

  1. A.Inhaled corticosteroids
  2. B.Mucolytics
  3. C.Anticholinergic bronchodilators
  4. D.Tricyclic antidepressants

Correct answer

Tricyclic antidepressants

Explanation

Tricyclic antidepressants may potentiate cardiovascular effects of sympathomimetic agents.

Question 11Difficulty 2/5

Albuterol-associated hypokalemia is especially concerning in a patient also receiving which medication?

  1. A.Montelukast
  2. B.Budesonide
  3. C.Guaifenesin
  4. D.Digoxin

Correct answer

Digoxin

Explanation

Hypokalemia can increase digoxin toxicity risk, so potassium monitoring matters.

Question 12Difficulty 2/5

Which finding is NOT an automatic contraindication to Albuterol?

  1. A.Milk protein allergy with certain dry powder inhalers
  2. B.Symptomatic tachyarrhythmia requiring immediate evaluation
  3. C.History of severe immediate allergic reaction to albuterol
  4. D.Requires bronchodilator response testing

Correct answer

Requires bronchodilator response testing

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 13Difficulty 2/5

Which patient factor is an absolute contraindication for Albuterol?

  1. A.Known paradoxical bronchospasm after previous albuterol treatment
  2. B.Severe hypersensitivity reaction after prior dose
  3. C.History of severe immediate allergic reaction to albuterol
  4. D.Hypersensitivity to albuterol or formulation components

Correct answer

Hypersensitivity to albuterol or formulation components

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 14Difficulty 2/5

Which finding should make the RT withhold Albuterol and notify the provider?

  1. A.History of severe immediate allergic reaction to albuterol
  2. B.Severe hypersensitivity reaction after prior dose
  3. C.Symptomatic tachyarrhythmia requiring immediate evaluation
  4. D.Hypersensitivity to albuterol or formulation components

Correct answer

Hypersensitivity to albuterol or formulation components

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 15Difficulty 2/5

An asthma patient receives frequent Albuterol while taking furosemide. Which electrolyte should the RT monitor most closely?

  1. A.Sodium
  2. B.Calcium
  3. C.Chloride
  4. D.Potassium

Correct answer

Potassium

Explanation

Frequent beta-agonist therapy plus loop diuretics increases hypokalemia risk.

Question 16Difficulty 3/5

Which medication group may increase cardiovascular stimulation when combined with Albuterol?

  1. A.Inhaled corticosteroids
  2. B.Anticholinergic bronchodilators
  3. C.Mucolytics
  4. D.Other sympathomimetic medications

Correct answer

Other sympathomimetic medications

Explanation

Combining sympathomimetics can increase tachycardia, palpitations, tremor, and blood pressure effects.

Question 17Difficulty 3/5

Which finding is NOT an automatic contraindication to Albuterol?

  1. A.Use of non-selective beta blockers
  2. B.Uncontrolled hyperthyroidism
  3. C.Severe hypokalemia
  4. D.Stable COPD

Correct answer

Stable COPD

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 18Difficulty 3/5

Which finding is NOT an automatic contraindication to Albuterol?

  1. A.History of severe immediate allergic reaction to albuterol
  2. B.Severe hypersensitivity reaction after prior dose
  3. C.Known paradoxical bronchospasm after previous albuterol treatment
  4. D.Breastfeeding

Correct answer

Breastfeeding

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 19Difficulty 3/5

Which medication may add to tremor, palpitations, or stimulant-like effects with Albuterol?

  1. A.Dornase alfa
  2. B.Normal saline nebulizer
  3. C.Inhaled tobramycin
  4. D.Theophylline

Correct answer

Theophylline

Explanation

Theophylline and other stimulant-like agents can add to tremor and palpitations with beta agonists.

Question 20Difficulty 3/5

Which medication class can potentiate cardiovascular effects from Albuterol?

  1. A.Inhaled corticosteroids
  2. B.Mucolytics
  3. C.Leukotriene receptor antagonists
  4. D.Monoamine oxidase inhibitors (MAOIs)

Correct answer

Monoamine oxidase inhibitors (MAOIs)

Explanation

MAOIs can potentiate adrenergic cardiovascular effects from beta agonists.

Question 21Difficulty 3/5

Which medication class may reduce the bronchodilator effect of Albuterol?

  1. A.Loop diuretics
  2. B.Digoxin
  3. C.Caffeine
  4. D.Non-selective beta blockers

Correct answer

Non-selective beta blockers

Explanation

Non-selective beta blockers can blunt beta-2 bronchodilation and may worsen bronchospasm.

Question 22Difficulty 3/5

Which finding is NOT an automatic contraindication to Albuterol?

  1. A.Current MAOI or tricyclic antidepressant use
  2. B.Seizure disorder with unstable control
  3. C.Symptomatic tachyarrhythmia requiring immediate evaluation
  4. D.Stable hypertension

Correct answer

Stable hypertension

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 23Difficulty 3/5

Which medication class increases concern for hypokalemia when combined with frequent Albuterol?

  1. A.Inhaled corticosteroids
  2. B.Mucolytics
  3. C.Antitussives
  4. D.Loop diuretics

Correct answer

Loop diuretics

Explanation

Loop diuretics can lower potassium, and beta-2 agonists can shift potassium intracellularly.

Question 24Difficulty 4/5

A patient on an MAOI develops worsening tachycardia after repeated Albuterol. What is the best interpretation?

  1. A.The interaction prevents all bronchodilation
  2. B.The combination eliminates tachycardia risk
  3. C.The finding is unrelated to adrenergic stimulation
  4. D.The interaction may potentiate sympathomimetic cardiovascular effects

Correct answer

The interaction may potentiate sympathomimetic cardiovascular effects

Explanation

MAOIs may potentiate cardiovascular responses to adrenergic medications.

Question 25Difficulty 4/5

Which patient factor is an absolute contraindication for Albuterol?

  1. A.Severe ischemic heart disease with active tachyarrhythmias
  2. B.Known paradoxical bronchospasm after previous albuterol treatment
  3. C.Milk protein allergy with certain dry powder inhalers
  4. D.Hypersensitivity to albuterol or formulation components

Correct answer

Hypersensitivity to albuterol or formulation components

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 26Difficulty 4/5

Albuterol-associated hypokalemia is especially concerning in a patient also receiving which medication?

  1. A.Montelukast
  2. B.Budesonide
  3. C.Guaifenesin
  4. D.Digoxin

Correct answer

Digoxin

Explanation

Hypokalemia can increase digoxin toxicity risk, so potassium monitoring matters.

Question 27Difficulty 4/5

A COPD patient taking propranolol has minimal response to repeated Albuterol. What is the best explanation?

  1. A.Inhaled corticosteroids block all beta-2 receptors
  2. B.Spacer use prevents bronchodilation
  3. C.Loop diuretics directly block airway beta receptors
  4. D.Non-selective beta blocker use may blunt the response

Correct answer

Non-selective beta blocker use may blunt the response

Explanation

Propranolol is a non-selective beta blocker and can oppose beta-2 agonist bronchodilation.

Question 28Difficulty 4/5

An asthma patient receives frequent Albuterol while taking furosemide. Which electrolyte should the RT monitor most closely?

  1. A.Sodium
  2. B.Calcium
  3. C.Chloride
  4. D.Potassium

Correct answer

Potassium

Explanation

Frequent beta-agonist therapy plus loop diuretics increases hypokalemia risk.

Question 29Difficulty 4/5

Which finding is NOT an automatic contraindication to Albuterol?

  1. A.Known paradoxical bronchospasm after previous albuterol treatment
  2. B.Use of non-selective beta blockers
  3. C.Uncontrolled hyperthyroidism
  4. D.Requires bronchodilator response testing

Correct answer

Requires bronchodilator response testing

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 30Difficulty 4/5

Which finding should make the RT withhold Albuterol and notify the provider?

  1. A.Known paradoxical bronchospasm after previous albuterol treatment
  2. B.Symptomatic tachyarrhythmia requiring immediate evaluation
  3. C.Uncontrolled hyperthyroidism
  4. D.Hypersensitivity to albuterol or formulation components

Correct answer

Hypersensitivity to albuterol or formulation components

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 31Difficulty 4/5

Which finding should make the RT withhold Albuterol and notify the provider?

  1. A.Diuretic-associated hypokalemia
  2. B.Recent myocardial infarction with unstable arrhythmias
  3. C.Use of non-selective beta blockers
  4. D.Hypersensitivity to albuterol or formulation components

Correct answer

Hypersensitivity to albuterol or formulation components

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 32Difficulty 4/5

Which drug class may increase cardiovascular sensitivity to Albuterol?

  1. A.Inhaled corticosteroids
  2. B.Mucolytics
  3. C.Anticholinergic bronchodilators
  4. D.Tricyclic antidepressants

Correct answer

Tricyclic antidepressants

Explanation

Tricyclic antidepressants may potentiate cardiovascular effects of sympathomimetic agents.

Question 33Difficulty 5/5

Which finding is NOT an automatic contraindication to Albuterol?

  1. A.Known paradoxical bronchospasm after previous albuterol treatment
  2. B.Diuretic-associated hypokalemia
  3. C.Symptomatic tachyarrhythmia requiring immediate evaluation
  4. D.Controlled hyperthyroidism

Correct answer

Controlled hyperthyroidism

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 34Difficulty 5/5

Which patient could safely receive Albuterol?

  1. A.Known paradoxical bronchospasm after previous albuterol treatment
  2. B.Uncontrolled hyperthyroidism
  3. C.Recent myocardial infarction with unstable arrhythmias
  4. D.Stable COPD

Correct answer

Stable COPD

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 35Difficulty 5/5

Which patient could safely receive Albuterol?

  1. A.Severe hypersensitivity reaction after prior dose
  2. B.Diuretic-associated hypokalemia
  3. C.Use of non-selective beta blockers
  4. D.Controlled hyperthyroidism

Correct answer

Controlled hyperthyroidism

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 36Difficulty 5/5

Which finding should make the RT withhold Albuterol and notify the provider?

  1. A.Milk protein allergy with certain dry powder inhalers
  2. B.Severe hypokalemia
  3. C.Use of non-selective beta blockers
  4. D.Hypersensitivity to albuterol or formulation components

Correct answer

Hypersensitivity to albuterol or formulation components

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 37Difficulty 5/5

Which finding should make the RT withhold Albuterol and notify the provider?

  1. A.Known paradoxical bronchospasm after previous albuterol treatment
  2. B.Symptomatic tachyarrhythmia requiring immediate evaluation
  3. C.Milk protein allergy with certain dry powder inhalers
  4. D.Hypersensitivity to albuterol or formulation components

Correct answer

Hypersensitivity to albuterol or formulation components

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 38Difficulty 5/5

Which patient factor is an absolute contraindication for Albuterol?

  1. A.Recent myocardial infarction with unstable arrhythmias
  2. B.History of severe immediate allergic reaction to albuterol
  3. C.Use of non-selective beta blockers
  4. D.Hypersensitivity to albuterol or formulation components

Correct answer

Hypersensitivity to albuterol or formulation components

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 39Difficulty 5/5

Which patient could safely receive Albuterol?

  1. A.History of severe immediate allergic reaction to albuterol
  2. B.Known paradoxical bronchospasm after previous albuterol treatment
  3. C.Diuretic-associated hypokalemia
  4. D.Mild resting tremor

Correct answer

Mild resting tremor

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 40Difficulty 5/5

Which finding should make the RT withhold Albuterol and notify the provider?

  1. A.Recent myocardial infarction with unstable arrhythmias
  2. B.Severe hypersensitivity reaction after prior dose
  3. C.Severe ischemic heart disease with active tachyarrhythmias
  4. D.Hypersensitivity to albuterol or formulation components

Correct answer

Hypersensitivity to albuterol or formulation components

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 41Difficulty 5/5

Which finding should make the RT withhold Albuterol and notify the provider?

  1. A.Severe hypokalemia
  2. B.History of severe immediate allergic reaction to albuterol
  3. C.Seizure disorder with unstable control
  4. D.Hypersensitivity to albuterol or formulation components

Correct answer

Hypersensitivity to albuterol or formulation components

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 42Difficulty 5/5

Which patient factor is an absolute contraindication for Albuterol?

  1. A.Known paradoxical bronchospasm after previous albuterol treatment
  2. B.Severe hypersensitivity reaction after prior dose
  3. C.Recent myocardial infarction with unstable arrhythmias
  4. D.Hypersensitivity to albuterol or formulation components

Correct answer

Hypersensitivity to albuterol or formulation components

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 43Difficulty 5/5

Which finding should make the RT withhold Albuterol and notify the provider?

  1. A.Severe hypokalemia
  2. B.Uncontrolled hyperthyroidism
  3. C.Current MAOI or tricyclic antidepressant use
  4. D.Hypersensitivity to albuterol or formulation components

Correct answer

Hypersensitivity to albuterol or formulation components

Explanation

Medication safety questions require separating absolute contraindications from cautions. For Albuterol, hypersensitivity to the drug or formulation components is the key contraindication. Cardiac disease, hypokalemia, beta-blockers, hyperthyroidism, and similar factors usually require caution, monitoring, or provider notification rather than automatic classification as the single absolute contraindication.

Question 44Difficulty 5/5

Which medication may add to tremor, palpitations, or stimulant-like effects with Albuterol?

  1. A.Dornase alfa
  2. B.Normal saline nebulizer
  3. C.Inhaled tobramycin
  4. D.Theophylline

Correct answer

Theophylline

Explanation

Theophylline and other stimulant-like agents can add to tremor and palpitations with beta agonists.

Question group

Adverse Effects

20 questions
Question 1Difficulty 1/5

A patient receives Albuterol. Which adverse effect is most likely?

  1. A.Urinary retention
  2. B.Blurred vision
  3. C.Lactic acidosis
  4. D.Tachycardia

Correct answer

Tachycardia

Explanation

Tachycardia is associated with Albuterol. Beta-agonist adverse effects commonly include tremor, tachycardia, palpitations, nervousness, and hypokalemia; paradoxical bronchospasm is rare but clinically important.

Question 2Difficulty 1/5

Which adverse effect is associated with Albuterol?

  1. A.Urinary retention
  2. B.Dry mouth
  3. C.Blurred vision
  4. D.Tachycardia

Correct answer

Tachycardia

Explanation

Tachycardia is associated with Albuterol. Beta-agonist adverse effects commonly include tremor, tachycardia, palpitations, nervousness, and hypokalemia; paradoxical bronchospasm is rare but clinically important.

Question 3Difficulty 1/5

Which adverse effect is associated with Albuterol?

  1. A.Lactic acidosis
  2. B.Urinary retention
  3. C.Dysphonia
  4. D.Tachycardia

Correct answer

Tachycardia

Explanation

Tachycardia is associated with Albuterol. Beta-agonist adverse effects commonly include tremor, tachycardia, palpitations, nervousness, and hypokalemia; paradoxical bronchospasm is rare but clinically important.

Question 4Difficulty 2/5

Which rare but important adverse effect is associated with Albuterol?

  1. A.Tendon rupture
  2. B.Pulmonary fibrosis
  3. C.Ototoxicity
  4. D.Paradoxical bronchospasm

Correct answer

Paradoxical bronchospasm

Explanation

Paradoxical bronchospasm is associated with Albuterol. Beta-agonist adverse effects commonly include tremor, tachycardia, palpitations, nervousness, and hypokalemia; paradoxical bronchospasm is rare but clinically important.

Question 5Difficulty 2/5

Which adverse effect is associated with Albuterol?

  1. A.Dry mouth
  2. B.Tendon rupture
  3. C.Lactic acidosis
  4. D.Palpitations

Correct answer

Palpitations

Explanation

Palpitations is associated with Albuterol. Beta-agonist adverse effects commonly include tremor, tachycardia, palpitations, nervousness, and hypokalemia; paradoxical bronchospasm is rare but clinically important.

Question 6Difficulty 2/5

A patient receives Albuterol. Which adverse effect is most likely?

  1. A.Oral candidiasis
  2. B.Pulmonary fibrosis
  3. C.Nephrotoxicity
  4. D.Tremor

Correct answer

Tremor

Explanation

Tremor is associated with Albuterol. Beta-agonist adverse effects commonly include tremor, tachycardia, palpitations, nervousness, and hypokalemia; paradoxical bronchospasm is rare but clinically important.

Question 7Difficulty 2/5

Which side effect should be anticipated with Albuterol?

  1. A.Tendon rupture
  2. B.Hepatotoxicity
  3. C.Urinary retention
  4. D.Tachycardia

Correct answer

Tachycardia

Explanation

Tachycardia is associated with Albuterol. Beta-agonist adverse effects commonly include tremor, tachycardia, palpitations, nervousness, and hypokalemia; paradoxical bronchospasm is rare but clinically important.

Question 8Difficulty 3/5

Which adverse effect is associated with Albuterol?

  1. A.Dysphonia
  2. B.Nephrotoxicity
  3. C.Hearing loss
  4. D.Tremor

Correct answer

Tremor

Explanation

Tremor is associated with Albuterol. Beta-agonist adverse effects commonly include tremor, tachycardia, palpitations, nervousness, and hypokalemia; paradoxical bronchospasm is rare but clinically important.

Question 9Difficulty 3/5

A patient receives Albuterol. Which adverse effect is most likely?

  1. A.Hepatotoxicity
  2. B.Blurred vision
  3. C.Tendon rupture
  4. D.Nervousness

Correct answer

Nervousness

Explanation

Nervousness is associated with Albuterol. Beta-agonist adverse effects commonly include tremor, tachycardia, palpitations, nervousness, and hypokalemia; paradoxical bronchospasm is rare but clinically important.

Question 10Difficulty 3/5

Which adverse effect is associated with Albuterol?

  1. A.Ototoxicity
  2. B.Hepatotoxicity
  3. C.Tendon rupture
  4. D.Tremor

Correct answer

Tremor

Explanation

Tremor is associated with Albuterol. Beta-agonist adverse effects commonly include tremor, tachycardia, palpitations, nervousness, and hypokalemia; paradoxical bronchospasm is rare but clinically important.

Question 11Difficulty 3/5

Which adverse effect is associated with Albuterol?

  1. A.Lactic acidosis
  2. B.Ototoxicity
  3. C.Dry mouth
  4. D.Nervousness

Correct answer

Nervousness

Explanation

Nervousness is associated with Albuterol. Beta-agonist adverse effects commonly include tremor, tachycardia, palpitations, nervousness, and hypokalemia; paradoxical bronchospasm is rare but clinically important.

Question 12Difficulty 4/5

Which reaction would require stopping Albuterol and reassessing therapy?

  1. A.Hepatotoxicity
  2. B.Dry mouth
  3. C.Hearing loss
  4. D.Paradoxical bronchospasm

Correct answer

Paradoxical bronchospasm

Explanation

Paradoxical bronchospasm is associated with Albuterol. Beta-agonist adverse effects commonly include tremor, tachycardia, palpitations, nervousness, and hypokalemia; paradoxical bronchospasm is rare but clinically important.

Question 13Difficulty 4/5

Which side effect should be anticipated with Albuterol?

  1. A.Dysphonia
  2. B.Ototoxicity
  3. C.QT prolongation
  4. D.Tremor

Correct answer

Tremor

Explanation

Tremor is associated with Albuterol. Beta-agonist adverse effects commonly include tremor, tachycardia, palpitations, nervousness, and hypokalemia; paradoxical bronchospasm is rare but clinically important.

Question 14Difficulty 4/5

Which rare but important adverse effect is associated with Albuterol?

  1. A.Hearing loss
  2. B.Urinary retention
  3. C.Oral candidiasis
  4. D.Paradoxical bronchospasm

Correct answer

Paradoxical bronchospasm

Explanation

Paradoxical bronchospasm is associated with Albuterol. Beta-agonist adverse effects commonly include tremor, tachycardia, palpitations, nervousness, and hypokalemia; paradoxical bronchospasm is rare but clinically important.

Question 15Difficulty 4/5

Albuterol commonly causes which side effect?

  1. A.Hyperglycemia
  2. B.Urinary retention
  3. C.Tendon rupture
  4. D.Tremor

Correct answer

Tremor

Explanation

Tremor is associated with Albuterol. Beta-agonist adverse effects commonly include tremor, tachycardia, palpitations, nervousness, and hypokalemia; paradoxical bronchospasm is rare but clinically important.

Question 16Difficulty 5/5

For board exams, which serious adverse effect should be linked to Albuterol?

  1. A.Tendon rupture
  2. B.Hyperglycemia
  3. C.Hepatotoxicity
  4. D.Paradoxical bronchospasm

Correct answer

Paradoxical bronchospasm

Explanation

Paradoxical bronchospasm is associated with Albuterol. Beta-agonist adverse effects commonly include tremor, tachycardia, palpitations, nervousness, and hypokalemia; paradoxical bronchospasm is rare but clinically important.

Question 17Difficulty 5/5

Which adverse effect is associated with Albuterol?

  1. A.Nephrotoxicity
  2. B.Tendon rupture
  3. C.Blurred vision
  4. D.Tachycardia

Correct answer

Tachycardia

Explanation

Tachycardia is associated with Albuterol. Beta-agonist adverse effects commonly include tremor, tachycardia, palpitations, nervousness, and hypokalemia; paradoxical bronchospasm is rare but clinically important.

Question 18Difficulty 5/5

Which side effect should be anticipated with Albuterol?

  1. A.Dry mouth
  2. B.Lactic acidosis
  3. C.Hyperglycemia
  4. D.Hypokalemia

Correct answer

Hypokalemia

Explanation

Hypokalemia is associated with Albuterol. Beta-agonist adverse effects commonly include tremor, tachycardia, palpitations, nervousness, and hypokalemia; paradoxical bronchospasm is rare but clinically important.

Question 19Difficulty 5/5

Which side effect should be anticipated with Albuterol?

  1. A.Dysphonia
  2. B.Urinary retention
  3. C.Ototoxicity
  4. D.Nervousness

Correct answer

Nervousness

Explanation

Nervousness is associated with Albuterol. Beta-agonist adverse effects commonly include tremor, tachycardia, palpitations, nervousness, and hypokalemia; paradoxical bronchospasm is rare but clinically important.

Question 20Difficulty 5/5

Albuterol commonly causes which side effect?

  1. A.Urinary retention
  2. B.Lactic acidosis
  3. C.Blurred vision
  4. D.Tachycardia

Correct answer

Tachycardia

Explanation

Tachycardia is associated with Albuterol. Beta-agonist adverse effects commonly include tremor, tachycardia, palpitations, nervousness, and hypokalemia; paradoxical bronchospasm is rare but clinically important.

Question group

Clinical Scenarios and NBRC Reasoning

33 questions
Question 1Difficulty 1/5

Which medication is considered a rescue bronchodilator?

  1. A.Budesonide
  2. B.Fluticasone
  3. C.Salmeterol
  4. D.Albuterol

Correct answer

Albuterol

Explanation

Albuterol is a short-acting beta-2 agonist used for rapid relief of acute bronchospasm.

Question 2Difficulty 2/5

Which medication is primarily a controller rather than a rescue medication?

  1. A.Albuterol
  2. B.Levalbuterol
  3. C.Epinephrine inhalation
  4. D.Salmeterol

Correct answer

Salmeterol

Explanation

Salmeterol is a long-acting beta-2 agonist and should not be used alone for acute symptom relief.

Question 3Difficulty 2/5

Which finding best indicates Albuterol therapy is working?

  1. A.Mild hand tremor
  2. B.Heart rate increases by 10 beats/min
  3. C.Dry mouth
  4. D.Improved air movement with decreased wheezing

Correct answer

Improved air movement with decreased wheezing

Explanation

Clinical improvement is demonstrated by better airflow, reduced wheezing, and decreased work of breathing rather than medication side effects.

Question 4Difficulty 2/5

A patient with diffuse wheezing receives an Albuterol nebulizer. Five minutes later, breath sounds improve and work of breathing decreases. What is the best interpretation?

  1. A.The medication has failed
  2. B.The patient has paradoxical bronchospasm
  3. C.The treatment should be repeated immediately
  4. D.The patient is responding appropriately to therapy

Correct answer

The patient is responding appropriately to therapy

Explanation

Improved airflow, reduced wheezing, and decreased work of breathing indicate effective bronchodilation.

Question 5Difficulty 2/5

Which statement about Albuterol is most accurate?

  1. A.It is primarily an anti-inflammatory medication
  2. B.It permanently reverses airway remodeling
  3. C.It replaces inhaled corticosteroids for long-term control
  4. D.It relieves bronchospasm but does not treat the underlying airway inflammation

Correct answer

It relieves bronchospasm but does not treat the underlying airway inflammation

Explanation

Albuterol rapidly relaxes airway smooth muscle but does not address chronic airway inflammation.

Question 6Difficulty 2/5

A patient with persistent asthma uses Albuterol four to five times every day. What does this most strongly suggest?

  1. A.Excellent asthma control
  2. B.Expected use of rescue therapy
  3. C.The patient should continue Albuterol alone indefinitely
  4. D.Poor asthma control requiring reassessment of controller therapy

Correct answer

Poor asthma control requiring reassessment of controller therapy

Explanation

Frequent rescue inhaler use suggests inadequate asthma control and should prompt reassessment of maintenance therapy.

Question 7Difficulty 2/5

Which medication works by blocking muscarinic receptors rather than stimulating beta-2 receptors?

  1. A.Albuterol
  2. B.Levalbuterol
  3. C.Formoterol
  4. D.Ipratropium

Correct answer

Ipratropium

Explanation

Ipratropium is a short-acting muscarinic antagonist, whereas Albuterol is a beta-2 agonist.

Question 8Difficulty 2/5

Following a nebulized Albuterol treatment, which assessment should improve if therapy is effective?

  1. A.Pupil size
  2. B.Skin temperature
  3. C.Abdominal tenderness
  4. D.Breath sounds and work of breathing

Correct answer

Breath sounds and work of breathing

Explanation

Effective bronchodilation should improve breath sounds, reduce wheezing, and decrease respiratory effort.

Question 9Difficulty 3/5

A patient receiving continuous Albuterol develops a heart rate of 154/min with new palpitations. What is the best RT action?

  1. A.Increase the Albuterol dose
  2. B.Continue therapy without reassessment
  3. C.Repeat the treatment immediately
  4. D.Stop, reassess the patient, and notify the provider

Correct answer

Stop, reassess the patient, and notify the provider

Explanation

Marked tachycardia and new palpitations during continuous beta-agonist therapy require stopping or pausing therapy, reassessing the patient, and notifying the provider.

Question 10Difficulty 3/5

A patient receiving repeated Albuterol treatments develops worsening tremor but improved breath sounds and oxygenation. What is the best RT interpretation?

  1. A.The patient is experiencing an allergic reaction
  2. B.The medication has failed
  3. C.Immediately discontinue all bronchodilator therapy
  4. D.Tremor is a common beta-2 agonist adverse effect; continue monitoring

Correct answer

Tremor is a common beta-2 agonist adverse effect; continue monitoring

Explanation

Tremor is a common beta-2 agonist effect. If breath sounds and oxygenation improve, continue monitoring while watching for worsening toxicity.

Question 11Difficulty 3/5

Which medication provides anti-inflammatory control rather than immediate bronchodilation?

  1. A.Albuterol
  2. B.Levalbuterol
  3. C.Ipratropium
  4. D.Budesonide

Correct answer

Budesonide

Explanation

Budesonide is an inhaled corticosteroid that reduces airway inflammation but is not a rescue medication.

Question 12Difficulty 3/5

Compared with Albuterol, which medication contains only the R-enantiomer of albuterol?

  1. A.Ipratropium
  2. B.Formoterol
  3. C.Salmeterol
  4. D.Levalbuterol

Correct answer

Levalbuterol

Explanation

Levalbuterol is the R-isomer of albuterol. Clinical benefit over racemic albuterol is generally modest.

Question 13Difficulty 3/5

Which patient is most likely to require controller medication in addition to Albuterol?

  1. A.A patient using Albuterol before occasional exercise only
  2. B.A patient with one mild exacerbation several years ago
  3. C.A patient using Albuterol once every few months
  4. D.A patient requiring rescue therapy multiple times each week

Correct answer

A patient requiring rescue therapy multiple times each week

Explanation

Frequent rescue medication use is a classic indication that controller therapy should be optimized.

Question 14Difficulty 3/5

A patient has diffuse wheezing before treatment and significantly improved breath sounds after Albuterol. Which finding best indicates treatment success?

  1. A.Heart rate increased by 20 beats/min
  2. B.The patient developed a mild tremor
  3. C.Respiratory rate stayed unchanged
  4. D.Improved air movement with decreased work of breathing

Correct answer

Improved air movement with decreased work of breathing

Explanation

Clinical improvement should be judged primarily by ventilation, work of breathing, oxygenation, and patient symptoms rather than expected side effects.

Question 15Difficulty 3/5

Following Albuterol therapy, which finding suggests worsening bronchospasm rather than medication success?

  1. A.Mild tremor
  2. B.Heart rate increased slightly
  3. C.Improved peak expiratory flow
  4. D.Increasing wheezing with worsening respiratory distress

Correct answer

Increasing wheezing with worsening respiratory distress

Explanation

Failure to improve or worsening respiratory status requires immediate reassessment and consideration of alternative diagnoses or escalation of therapy.

Question 16Difficulty 3/5

After repeated Albuterol treatments, a patient develops tremor but reports easier breathing. What is the best interpretation?

  1. A.Life-threatening toxicity requiring immediate intubation
  2. B.Paradoxical bronchospasm
  3. C.Medication failure
  4. D.Therapeutic bronchodilation with a common beta-2 agonist side effect

Correct answer

Therapeutic bronchodilation with a common beta-2 agonist side effect

Explanation

Tremor is a common dose-related beta-2 agonist effect and does not necessarily require discontinuation if the patient is otherwise improving.

Question 17Difficulty 3/5

A patient continues to wheeze after an Albuterol MDI treatment. What should the RT assess first?

  1. A.Blood glucose
  2. B.Renal function
  3. C.Chest tube placement
  4. D.Inhaler technique and medication delivery

Correct answer

Inhaler technique and medication delivery

Explanation

Poor inhaler technique is a common cause of inadequate bronchodilator response.

Question 18Difficulty 3/5

During continuous Albuterol therapy, which parameter deserves the closest ongoing monitoring?

  1. A.Liver enzymes
  2. B.Platelet count
  3. C.White blood cell count
  4. D.Heart rate and cardiac rhythm

Correct answer

Heart rate and cardiac rhythm

Explanation

Continuous beta-agonist therapy increases the risk of tachycardia and arrhythmias.

Question 19Difficulty 4/5

Which medication should generally NOT be used as the sole treatment for an acute asthma exacerbation?

  1. A.Albuterol
  2. B.Levalbuterol
  3. C.Ipratropium
  4. D.Salmeterol

Correct answer

Salmeterol

Explanation

LABAs have delayed onset compared with SABAs and are not appropriate as rescue monotherapy.

Question 20Difficulty 4/5

An RT administers Albuterol to an intubated patient with severe bronchospasm. Which bedside finding best demonstrates effective treatment?

  1. A.Higher ventilator alarms
  2. B.Increasing ET tube cuff pressure
  3. C.Lower oxygen saturation
  4. D.Lower peak inspiratory pressures with improved tidal volume delivery

Correct answer

Lower peak inspiratory pressures with improved tidal volume delivery

Explanation

Reduced airway resistance commonly lowers peak inspiratory pressure and improves ventilator mechanics.

Question 21Difficulty 4/5

A patient continues to wheeze after two properly administered Albuterol treatments. What should the RT consider next?

  1. A.Continue treatments indefinitely without reassessment
  2. B.Discontinue all bronchodilators permanently
  3. C.Switch immediately to antibiotics
  4. D.Notify the provider because additional therapy or escalation may be needed

Correct answer

Notify the provider because additional therapy or escalation may be needed

Explanation

Persistent bronchospasm despite appropriate therapy should prompt reassessment and escalation according to the clinical picture.

Question 22Difficulty 4/5

After multiple Albuterol treatments, an ICU patient develops increasing ventricular ectopy. Which laboratory value should be checked first?

  1. A.Hemoglobin
  2. B.Platelet count
  3. C.Serum bicarbonate
  4. D.Serum potassium

Correct answer

Serum potassium

Explanation

Frequent beta-2 agonist therapy can shift potassium intracellularly and contribute to hypokalemia, which may worsen ectopy or arrhythmia risk.

Question 23Difficulty 4/5

A patient receives repeated Albuterol treatments with minimal improvement. What should the RT assess before assuming medication failure?

  1. A.Patient blood type
  2. B.Liver function tests
  3. C.Hemoglobin A1c
  4. D.Inhaler or nebulizer delivery technique

Correct answer

Inhaler or nebulizer delivery technique

Explanation

Before assuming drug failure, the RT should assess delivery technique, device setup, dose delivery, severity of obstruction, and whether adjunct therapy is needed.

Question 24Difficulty 4/5

An intubated ICU patient requires bronchodilator therapy. Which approach is appropriate?

  1. A.Disconnect the ventilator for each treatment
  2. B.Administer oral tablets through the feeding tube for immediate bronchodilation
  3. C.Delay bronchodilator therapy until extubation
  4. D.Deliver Albuterol through the ventilator circuit using an inline nebulizer or MDI adapter

Correct answer

Deliver Albuterol through the ventilator circuit using an inline nebulizer or MDI adapter

Explanation

Inline nebulizers and MDI adapters allow effective aerosol delivery during mechanical ventilation.

Question 25Difficulty 4/5

Which laboratory value is most important to monitor during prolonged high-dose Albuterol therapy?

  1. A.Serum calcium
  2. B.Serum phosphorus
  3. C.Serum magnesium
  4. D.Serum potassium

Correct answer

Serum potassium

Explanation

High-dose beta-2 agonists shift potassium intracellularly and may produce clinically significant hypokalemia.

Question 26Difficulty 4/5

Which bronchodilator has the fastest onset for acute asthma symptom relief?

  1. A.Tiotropium
  2. B.Budesonide
  3. C.Salmeterol
  4. D.Albuterol

Correct answer

Albuterol

Explanation

Albuterol has a rapid onset of action and is the standard rescue bronchodilator.

Question 27Difficulty 4/5

A patient says, "My rescue inhaler works so well that I stopped taking my inhaled corticosteroid." What is the best RT response?

  1. A.That is appropriate because Albuterol prevents airway inflammation
  2. B.Only use the corticosteroid during acute attacks
  3. C.Use Albuterol every four hours instead of the controller
  4. D.Continue the prescribed controller because Albuterol does not replace anti-inflammatory therapy

Correct answer

Continue the prescribed controller because Albuterol does not replace anti-inflammatory therapy

Explanation

This is one of the most common board-style misconceptions. Rescue bronchodilators do not replace controller medications.

Question 28Difficulty 5/5

Which assessment best determines whether Albuterol is working?

  1. A.Presence of tremor alone
  2. B.Increase in heart rate alone
  3. C.Completion of the nebulizer treatment
  4. D.Improved patient symptoms together with objective improvement in airflow

Correct answer

Improved patient symptoms together with objective improvement in airflow

Explanation

Response to bronchodilator therapy should combine patient symptoms with objective respiratory findings such as breath sounds, airflow, peak flow, or ventilator mechanics.

Question 29Difficulty 5/5

A patient receiving continuous Albuterol develops worsening tachycardia and ventricular ectopy. What is the RT priority?

  1. A.Increase the treatment frequency
  2. B.Continue therapy because tachycardia is always expected
  3. C.Administer another bronchodilator immediately
  4. D.Stop the treatment, reassess, obtain vital signs, and notify the provider

Correct answer

Stop the treatment, reassess, obtain vital signs, and notify the provider

Explanation

New significant arrhythmias during continuous beta-agonist therapy require immediate reassessment and provider notification.

Question 30Difficulty 5/5

Which concept is tested most frequently regarding Albuterol on respiratory board examinations?

  1. A.It is the preferred long-term controller for persistent asthma
  2. B.It reduces airway inflammation better than inhaled corticosteroids
  3. C.It should routinely replace LABA therapy
  4. D.It is a rescue bronchodilator with rapid onset but short duration

Correct answer

It is a rescue bronchodilator with rapid onset but short duration

Explanation

Students commonly confuse rescue and controller medications. Recognizing Albuterol as a rapid-onset, short-duration SABA is a foundational NBRC concept.

Question 31Difficulty 5/5

A patient taking propranolol has persistent wheezing despite repeated Albuterol. Which explanation is most likely?

  1. A.Albuterol causes permanent beta receptor downregulation after one dose
  2. B.Nebulizers cannot deliver beta agonists effectively
  3. C.The patient requires immediate intubation
  4. D.Non-selective beta blockade may blunt the bronchodilator response

Correct answer

Non-selective beta blockade may blunt the bronchodilator response

Explanation

Propranolol is a non-selective beta blocker and can oppose beta-2 agonist bronchodilation.

Question 32Difficulty 5/5

Which medication is most commonly paired with Albuterol during moderate to severe asthma exacerbations in the emergency department?

  1. A.Montelukast
  2. B.Budesonide
  3. C.Tiotropium
  4. D.Ipratropium

Correct answer

Ipratropium

Explanation

Nebulized ipratropium is commonly added to albuterol during moderate and severe asthma exacerbations.

Question 33Difficulty 5/5

Which finding should prompt immediate reassessment during continuous Albuterol administration?

  1. A.Mild improvement in wheezing
  2. B.Slight hand tremor
  3. C.Respiratory rate decreases from 28 to 22 breaths/min
  4. D.New ventricular arrhythmias

Correct answer

New ventricular arrhythmias

Explanation

Development of ventricular arrhythmias during continuous beta-agonist therapy requires immediate reassessment and provider notification.

Related study paths

Continue building pharmacology mastery

Use this medication page as a reference, then reinforce it with interactive practice and related PulmTools study resources.

Browse respiratory pharmacologyPharmaGenius quizPulmTools learn library